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Stroke is a leading cause of death and disability globally.  The vast majority of all strokes 
occur in low- and middle-income countries, where data are least available to guide 
clinical decision-making and health policy.  Many strokes are preventable, and 
established risk factors for stroke are well-known in the scientific literature.  However, 
some risk factors may be less well-recognized but have a particular influence in specific 
subpopulations. Here, three risk factors for strokes are studied in three separate 
populations.  Fatal stroke in Bangladesh is studied with an emphasis on the potential role 
of betel nut as a stroke risk factor.  Human Immunodeficiency Virus infection and its 
relationship to stroke, including use of the predictive Framingham Risk Score, is studied 
in men who have sex with men in the United States.  Finally, groundwater arsenic 
exposure in American Indians is analyzed as a risk factor for carotid artery disease 
endpoints which are subclinical measurement that directly relate to stroke risk. The 
relationship between these risk factors and stroke, including their implications for 
younger-onset stroke, stroke prevention, and advocacy for vascular diseases on the global 
health agenda are emphasized.  
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Stroke, a sudden, often catastrophic, disruption in cerebral blood supply, is a leading 
cause of mortality worldwide.  Stroke accounts for 5.5 million of the 55 million deaths 
that occur globally each year (Mathers 2006).  In Japan, the country with the longest life 
expectancy from birth, improvements in life expectancy are partially attributed to the 
large reduction in stroke mortality rates in the 1960s (Ikeda 2011).  In the United States, 
it is estimated that someone suffers from a stroke every 40 seconds and dies from a stroke 
every 4 minutes (American Stroke Association 2012).  Today, more than 85 percent of all 
strokes occur in low and middle income countries (Strong 2007).  A meta-analysis of 
stroke incidence in high- versus low- and middle-income countries over a recent four-
decade period found a statistically significant difference in stroke incidence with a 42% 
decrease in high-income countries and a greater than 100% increase in low- and middle-
income countries (Feigin 2009).  Stroke incidence is now higher in low- and middle-
income countries than in high-income countries even though life expectancy is higher in 
wealthier settings. 
A majority of strokes, approximately 80%, are ischemic in nature, due to the sudden 
interruption in cerebral blood flow causing loss of oxygenation and nutrient availability 
to the brain tissue.  Hemorrhagic stroke accounts for approximately 20% of all strokes, 
although the proportion may differ depending on the population and its underlying 
demographic profile and risk factors.  For example, in China nearly 30% of strokes are 
hemorrhagic compared to 10% in Denmark (Zhang 2003, Andersen 2009). 
Approximately 25 percent of people with stroke die within the first month and half are 
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dead within one year (Donnan 2008, Hankey 2000).  In high income settings, more than 
20 percent of people ages 15 to 44 years old die within one month of their first stroke 
(Groppo 2012).  Although stroke is more common in men, women are more likely to 
experience fatal stroke (Reeves 2008).   A majority of people at high risk for stroke are 
unaware of its major risk factors and its presenting features.  This suboptimal awareness 
of stroke is more common in the highest risk groups, including older women and ethnic 
minorities (Ferris 2005). 
A high number of strokes are preventable in all countries.  A recent case-control study of 
3000 cases and 3000 controls in 22 countries on 5 continents found that 90 percent of the 
risk of stroke could be accounted for by 10 risk factors (O’Donnell 2010).  Risk factors 
for stroke may be separated into modifiable and non-modifiable components.  Age is the 
most important non-modifiable risk factor for stroke with the risk of stroke doubling for 
every decade of life after age 55 years old (American Stroke Association 2012).  In 1991, 
the Framingham Heart Study created a 10-year risk of stroke “health appraisal function” 
using 9 risk factors.  These included age, systolic blood pressure, the use of 
antihypertensive therapy, diabetes mellitus, cigarette smoking, prior cardiovascular 
disease (coronary heart disease, cardiac failure, or intermittent claudication), atrial 
fibrillation, and left ventricular hypertrophy by electrocardiogram (Wolf 1991).   
The American Heart Association recognizes age, family history, African American race, 
sex, and prior stroke, transient ischemic attack, or heart attack as non-modifiable risk 
factors for stroke.  Potentially modifiable risk factors for stroke are common and include 
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high blood pressure, cigarette smoking, diabetes mellitus, carotid or other artery disease, 
peripheral artery disease, atrial fibrillation, other heart disease (e.g. dilated 
cardiomyopathy), sickle cell anemia, high blood cholesterol, poor diet (i.e. high saturated 
and trans-fat diets and cholesterol), and physical inactivity and obesity.   As a response to 
these known risk factors, there is a public health initiative to attack the “simple 7” steps 
that an individual should take to reduce his or her risk of stroke:  (1) get active, (2) eat 
better, (3) lose weight, (4) stop smoking, (5) control cholesterol, (6) manage blood 
pressure, and (7) reduce blood sugar (American Stroke Association 2012).  
Emerging evidence however suggests that there are environmental and other exogenous 
risk factors for stroke that may often go unrecognized.  These include ambient 
temperature, season, air and water pollutants, geographic location, infections, 
medications, and tobaccos among environmental and exogenous risks.  Although 
exogenous and environmental risk factors are less well-documented, they may be 
pervasive, modifiable, and synergistic with other comorbidities in some populations.  The 
American Heart Association recognizes drug abuse, notably cocaine, alcohol abuse, 
nondescript socioeconomic factors, and geographic location among the “other” risk 
factors for stroke in populations. In some cases, these risk factors directly affect an 
individual’s risk of hypertension or heart disease, making the direct impact of the risk 
factor on the pathophysiology of the cerebrovasculature difficult to separate from 
important stroke risk factors.   
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Emerging environmental and exogenous risk factors for stroke may be poorly studied 
because the populations at risk are marginalized, difficult to engage in research studies, 
difficult to access geographically, or not routinely studied for vascular disease due to 
competing priorities in the study of risks for communicable diseases.  Stroke registries 
and stroke units in developing countries remain uncommon (Langhorne 2012).  When 
present, stroke centers are found in urban locations where environmental risks may not be 
most pronounced and many at-risk populations will be unable to access comprehensive 
care.  In high income countries, epidemiological studies of cardiovascular and 
cerebrovascular disease may also poorly capture unique stroke risk factors.   Major 
studies including the Framingham study, the Cardiovascular Health Study (CHS), and the 
Atherosclerosis in Communities (ARIC) study recruited volunteers.  Age restriction is 
also common including the MONICA study by the World Health Organization (limited 
mostly to <65 years old), Framingham study (recruitment of 30 to 60 year olds), CHS 
(>65 years old), and ARIC (45 to 64 years old) (Rothwell 2005).  Study sites near major 
academic centers may be convenient to study traditional risk factors in urbanized 
populations but are less ideal for studying particular environmental risks and populations 
with the highest degrees of poverty.    
Overview of the Non-hereditary, Environmental Risk Factors for Ischemic and 
Hemorrhagic Stroke 
The following section will provide a topical overview of important, non-hereditary, and 
emerging risk factors for ischemic and hemorrhagic stroke worldwide.  Although this is 
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not an exhaustive review of the entire literature of the putative risk factor for all 
populations, the aim of this section is to highlight the range, magnitude, and potential 
impact of these risk factors as well as provide insight into the state of the scientific and 
epidemiological literature on the risk factor from various locations.   All included articles 
are from peer-reviewed journals and represent original research or reviews of research 
studies.   
Ambient Temperature, Time, and Season 
The relationship between stroke and ambient temperature has been debated for several 
decades.  Blood pressure is known to be higher in winter months (Brennan 1982). There 
is no consensus on the relationship between ischemic and hemorrhagic stroke and 
ambient temperature, although extremes of temperature may have an important effect on 
stroke incidence and mortality.  Likely, many locations are non-comparable and 
ecological associations with temperature depend strongly on the underlying risk factors in 
the population.  Notably, locations of more sustained extreme heat are less likely to have 
population-based stroke registries.  In Chinese individuals in Taiwan, a U-shaped 
relationship between temperature and cerebral infarction was noted with the least number 
of deaths reported at days with temperatures between 27 to 29 degrees Celsius (Pan 
1995).  When the temperature was 32 degrees, the risk of ischemic stroke in people over 
64 years old was 66 percent higher compared to the 27 to 29 degree Celsius range.  
Mortality due to hemorrhagic stroke decreased by 3.3% for every 1 degree Celsius 
increase in temperature.   By contrast, a report of the Framingham Study (Kelly-Hayes 
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1995) found that the incidence of embolic stroke among people aged 30 to 62 years old 
peaked in winter during a 40-year observation period.  In Japan (Shinkawa 1990), stroke 
incidence varied by season for those with hypertension, normotension, and both elevated 
cholesterol and low cholesterol levels.  High intra-diurnal temperature change and lower 
temperature predicted increased incidence of both hemorrhagic and ischemic stroke 
(Shinkawa 1990).  In Oxfordshire, England, an increased incidence of ischemic stroke 
was noted in summer months, but there was an overall non-significant variation of stroke 
incidence by season (Rothwell 1996).  Primary intracerebral hemorrhage occurred more 
often than expected at temperatures less than 2 degrees Celsius.  It was concluded that the 
excess ischemic strokes seen in winter in other studies was due to excess mortality during 
wintertime strokes and the use of mortality registries for describing stroke incidence.   
The Framingham Study noted increased stroke incidence by day of the week (Monday) 
and time of day (8 AM to noon) (Kelly-Hayes 1995).  The increased incidence of stroke 
on Mondays was attributed to starting the new work week in the United States.  Multiple 
subsequent studies have related the morning surge in mean blood pressure with a peak 
risk of stroke during the morning hours of the day, including higher likelihood of fatal 
stroke (Shimizu 2011). 
Geographic Location 
Location of birth and residence can impact incidence of stroke.  One of the best studied 
examples of the influence of location is the so-called “stroke belt” in the Southeastern 
United States.  The term “stroke belt” came into use in the 1960s to describe the 
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nonrandom, extreme magnitude of difference in stroke incidence between this region and 
the rest of the U.S.  The National Heart, Lung, and Blood Institute (NHLBI) described 
the stroke belt as a 1980 age-adjusted stroke mortality rate of 10% or more above the 
national average.  This included Alabama, Arkansas, Georgia, Indiana, Kentucky, 
Louisiana, Mississippi, North and South Carolina, Tennessee, and Virginia (Lanska 
1995).  In the 1920s, stroke incidence was likely highest in the northeast Atlantic states, 
but this incidence gradually fell, leaving the excess stroke incidence in the southern 
states.   Notably, the stroke belt is not subject to political or state boundaries and affects 
both sexes and whites and blacks.  Both birth and adult residence in the stroke belt 
predict stroke mortality (Glymour 2009). Chronic disease prevalence, socioeconomic 
status, dietary intake, and race account for some but not all of the heightened risk of 
stroke (Lanska 1995, Liao 2009).  Geographic variations have also been noted in other 
countries, including Spain and China (Castilla-Guerra 2010, Chau 2011).  High altitude 
may also be a risk factor for stroke in some countries, but has been studied in a limited 
manner.  In one population-based study in Peru, the risk of stroke was higher in a high 
altitude town of Cuzco (3380 meters above sea level), which was related to polycythemia 
vera, but also lifestyle factors such as sedentary lifestyle and alcohol use (Jaillard 1995). 
A study of high altitude counties in the United States found no significant relationship 





Air pollution is composed of a heterogeneous mixture of particulate matter and gases 
(e.g. ozone, carbon monoxide). Early studies, including analyses of the Great London 
Fog of 1952, a renowned pollution episode of the 20th century, found an increased risk of 
stroke deaths attributable to a short-term extreme rise in air pollution (Logan 1953). This 
relationship continues to be demonstrated even at lower levels. In most cases, exposure to 
each pollutant reported, including gases and particles of varying sizes, is associated with 
an increased risk of cerebrovascular events. Numerous between-study differences exist, 
including demographic characteristics, measured pollutants, temporal risk associations, 
and the ascertainment of stroke and stroke outcomes, making direct comparisons 
difficult. However, the relative risk for stroke-related mortality may reach 2.04 for a 21.3 
μg/m3-increase in same-day PM10 levels (elderly individuals in Seoul, South Korea) 
(Hong 2002), whereas the incidence rate increase for stroke hospitalizations may reach 
13% (95% confidence interval [CI], 4%-22%) when previous-day PM10 levels are greater 
than 30 μg/m3 vs. less than 15 μg/m3 (in Sweden) (Oudin 2010).  In general, the risk of 
stroke appears to be greater for ischemic stroke compared with hemorrhagic stroke, and 
the association with PM is at least as strong as with gaseous pollutants. 
In a prospective study that evaluated both stroke and heart disease outcomes in women 
(Miller 2007), long-term exposure to air pollution was associated with an increased risk 
for a cerebrovascular disease event (odds ratio, 1.35; 95% CI, 1.08-1.68) that was 
comparable with that for myocardial infarction (odds ratio, 1.06; 95% CI, 0.85-1.34) and 
all coronary disease events (odds ratio, 1.21; 95% CI, 1.08-1.68). 
9 
 
Multiple heavy metals found in the environment have had inconsistent links to the risk of 
stroke.  Special attention will be given to arsenic since it will be the focus of a part of this 
thesis proposal.  Arsenic has been identified as a potential risk factor for cerebrovascular 
disease, particularly through its putative role in potentiating atherosclerosis (Engel 1994, 
Simeonova 2004).  In concentrations >500 micrograms/L, arsenic in drinking water has 
been associated with increased risk of ischemic heart disease and carotid atherosclerosis 
(Chen 2011), and possibly hypertension (Abhyankar 2012).  The relationship between 
arsenic ingestion and stroke incidence and stroke fatality is not well established.  A 
systematic review of the relationship between arsenic exposure and incident stroke found 
the relative risk to be 1.19-2.69 in studies from Taiwan, 0.69-1.53 in general populations 
elsewhere, and 0.30-1.33 for stroke fatality in occupationally exposed populations (Navas 
Acien 2005).   An ecological study of arsenic levels, using population-weighted average 
arsenic concentrations by county in Michigan found a modestly increased relative risk of 
stroke hospitalization (1.03, 95% CI 1.01-1.05) per microgram/L increase in arsenic 
exposure in the county (Lisabeth 2010).  However, similar degrees of association were 
observed between county-level arsenic exposure and duodenal ulcer and hernia, diseases 
which lack a known relationship with arsenic exposure.  In Taiwan, where arsenic levels 
are generally higher than in the USA, a dose-dependent relationship was found between 
measured arsenic concentrations in the well water of 8102 participants and the prevalence 
of cerebral infarction with odds ratios of 1.0, 3.4, 4.5, and 6.9 for well water with arsenic 
content of <0.1, 0.1-50.0, 50.1-299.9, and >300 micrograms/L, respectively (Chiou 
1997).  There was a biological gradient between long-term arsenic exposure and carotid 
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atherosclerosis in one study of endemic arseniasis in Taiwan (Wang 2002). Important 
limitations of previous research include ecological designs, lack of adjustment for 
relevant confounders, uncertain outcome ascertainment, and lack of information on stroke 
subtype.         
Cadmium has been less well studied.  One report of 50 maintenance hemodialysis 
patients without known atherosclerotic disease found that cadmium was an independent 
determinant of carotid intimal-medial thickness (CIMT) compared to age- and sex-
matched individuals (Ari 2011).  The Atherosclerosis Risk Factors in Female Youngsters 
study identified cadmium as an independent risk factor for high CIMT as well (Messner 
2009).  Cadmium is associated with lower aortic pulse wave velocity, lower pulse 
pressure in multiple arteries, and higher femoral distensibility (Schutte 2007), as well as 
prevalence of stroke and heart failure using retrospective self-report data (Peters 2010). 
Infections 
Multiple infections have been associated with later risk of stroke.  These can be separated 
into acute systemic infection, chronic systemic infection, and nervous system-specific 
infection. There is also recognition that influenza vaccine is associated with stroke, 
although the relationship remains unclear. Nonspecific systemic infection, most 
commonly upper respiratory tract infections, may predispose to stroke risk for 
approximately 1 week following the infectious illness (Grau 2010).  Likely, it is the 
nonspecific procoagulant effects of the infectious illness and an inflammatory response 
affecting the vasculature that are important to the host rather than a specific microbial 
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agent.  Chronic infectious states that may predispose to stroke include periodontitis, 
chronic bronchitis, infection with Helicobacter pylori, and infection with Chlamydia 
pneumoniae. Specific known agents which increase the risk of stroke in some individuals 
include Treponema pallidum (neurosyphilis), Mycobacterium tuberculosis 
(neurotuberculousis), Borrelia burgdoferi (intracranial vasculitis), and rickettsial diseases 
among bacteria (Grau 2010).    
Several studies have suggested an increased risk of stroke in HIV+ adults (Evers 2003, 
Cole 2004, Corral 2009, Rasmussen 2011, Chow 2012, Vinikoor 2013).  One study from 
Spain found that high alcohol intake, a history of a diagnosis of AIDS, and fewer months 
on HAART increased the risk of stroke, although only 25 patients with stroke were 
identified (Corral 2009).  HIV infection itself may portend a higher stroke risk, even 
when accounting for demographic and traditional stroke risk factors. A U.S. study found 
that HIV remained an independent predictor for stroke when comparing HIV+ versus 
HIV- individuals from different cohorts even after adjustment for known risk factors.  
Most others in high income settings suggest that HIV increases stroke risk.  In South 
Africa, however, most studies report similarities in patient characteristics and stroke 
incidence between HIV+ and HIV- groups (Hoffmann 2000, Mochan 2003, Patel 2005). 
The reasons for increased rates of stroke among HIV+ men could include such 
mechanisms as chronic inflammation leading to atherogenic tendency of the endothelium, 
remodeling of the intracranial and carotid vasculature, and higher frequency of 
circulating inflammatory markers (Ortiz 2007, Seaberg 2010, Falcone 2011, Sen 2012).  
In the multinational STACCATO study (Calmy 2009), inflammatory markers associated 
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with increased cardiovascular risk, such as soluble vascular adhesion molecule-1 
(sVCAM-1), were associated with HIV RNA replication and decreased with HAART 
initiation.  In a separate study by the SMART/INSIGHT and D.A.D. working groups 
(SMART 2008), Abacavir, found in some HAART regimens, was associated with an 
increased risk of all-cause cardiovascular disease which included stroke.  The relationship 
between HAART and longterm stroke risk in general requires further investigation since 
typical antiretroviral treatment has changed over time.  There may also be important risk 
factors that confound the relationship between stroke and HIV such as injection drug 
abuse with cocaine, excessive alcohol use, or poor medication adherence.   
 
Herpes zoster and herpes simplex viruses may increase the risk of stroke, particularly in 
the immunosuppressed.  Hyperviscosity may result from cryoglobulinemia in specific 
hepatitides (e.g. hepatitis C).  Multiple fungal infections may invade the cerebral 
vasculature with Aspergillus fumigatus being an important cause of hemorrhagic stroke in 
the immunosuppressed.  Parasites such as Trypansoma cruzi may increase the stroke risk 
through dilated cardiomyopathy which predisposes to intracardiac thrombosis and 
embolic phenomena. Schistosomiasis may lead to a vasculitic type of stroke.  
 
Dietary Components 
There is a significant association between stroke risk and the number of fast food 
restaurants in a neighborhood, even after controlling for demographic characteristics and 
socioeconomic status (Morgenstern 2009). Perhaps the most ubiquitous dietary risk factor 
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for stroke is salt consumption (Brown 2009).  Deliberate and significant reductions in salt 
intake through efforts in the food industry and public health campaigns over more than 2 
decades have been associated with an approximately 60% reduction in stroke mortality in 
Finland (Puska 1998). In the Northern Manhattan Study (NOMAS), the risk of stroke 
increased by 17% (95% CI 7-27%) for each 500mg/day increase in mean daily sodium 
intake (Gardener 2012). A large meta-analysis involving more than 5000 acute vascular 
events found that a 5-gram daily difference in salt intake represented a 23% difference in 
risk of fatal and nonfatal stroke (Strazzullo 2009). 
In terms of full dietary approaches, the Mediterranean or DASH (Dietary Approaches to 
Stop Hypertension) diets, diets high in potassium, low-salt and low-added sugar diets, 
and diets that are at the daily recommended energy requirements may lower stroke risk 
(Hankey 2012).  Multiple nutrients have been studied in detail.  Notably, high chocolate, 
high whole grain, moderate coffee (3-4 cups/day), moderate tea (3 or more cups/day), 
reduced-fat milk, fish, and high fruit and vegetable (5 or more servings daily) are all 
associated with lowered stroke risk.  By contrast, processed meat, total meat, and sodas 
are associated with increased stroke risk.  There was no recognizable effect of full-
strength milk, unprocessed meats, or rice (Hankey 2012).  Further work on carotenoids, 
flavonoids, ω3-fatty acids, and high glycemic index foods is required (Medeiros 2012).  
Dietary supplementation with vitamin C, vitamin E, beta-carotene, and calcium do not 
prevent stroke.  Vitamin A and E supplementation may increase all-cause mortality, and 
vitamin D supplementation is being studied.  Potassium supplementation may reduce 
stroke risk (Hankey 2012).  
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Tobaccos and Medications 
Multiple medications have been associated with stroke.  The most important of these in 
recent years have been selective cyclooxygenase-2 inhibitors (Vioxx, Rofecoxib), widely 
prescribed for inflammatory pain, and phenylpropanolamine  which was commonly 
found in over-the-counter cough and cold remedies as well as appetite suppressants in the 
U.S. (Kernan 2000; Baron 2008; Roumie 2008).  Oral hormone replacement therapy, at 
one time thought to reduce the risk of cardiovascular disease, is associated with an 
approximately 30-40 percent increase in ischemic stroke.  This has been found with both 
estrogen and combination of estrogen and progesterone hormone replacement 
(Wassertheil-Smoller 2003, Arana 2006, Sare 2008). The use of transdermal estrogens 
however does not appear to increase the risk of stroke based on a recent case control 
study of more than 15,710 cases of stroke including 103 transdermal estrogen patch users 
(Renoux 2012).  Oral contraceptive pill use is also associated with a modest increase in 
atherothrombotic stroke risk, as very recently reported by observation of more than 1.6 
million Danish women on various hormonal combinations (Lidegaard 2012).  
Cigarette smoking is a well-recognized risk factor for stroke and has been reviewed in 
detail elsewhere (Shinton 1989, Ockene 1997).  Importantly, passive, chronic exposure to 
cigarette smoke can also increase the risk of hemorrhagic and ischemic stroke in never-
smokers (Zhang 2005, He 2008). There have been few prior studies on the risk of stroke 
from betel nut consumption.  In a prospective cohort study (Wen 2005), The Survey of 
Health and Living Status of the Near Elderly and Elderly in Taiwan, past or current betel 
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nut chewing increased the risk of stroke death in individuals age 50 years and older 
(hazard ratio 1.66, 95% CI 1.19-2.30).   However, only 14% of the cohort had ever 
chewed betel nut and they accounted for just 51 stroke deaths.  In a separate Taiwanese 
study in 2001, based on the National Health Interview Survey, the relative risk of stroke 
death among betel chewers was 1.3 (95% CI 0.8-2.2).  There were 22 stroke deaths 
among betel chewers, all of whom also smoked tobacco (Lan 2007).   
Life Events and Social Setting 
Life events may be a trigger for ischemic strokes.  A Canadian study of 24,315 
emergency room visits for stroke and 16,088 visits for transient ischemic attacks, and 
29,090 for acute myocardial infarction found that all three events occurred with higher 
than expected frequency on the patient’s birthday.  A similar association was not 
observed for the control conditions of asthma, appendicitis, or head trauma.  The risk was 
higher in patients with known hypertension, suggesting that stress associated with 
birthdays may trigger strokes and TIAs in patients with predisposition to these disorders 
(Saposnik 2006).  In Finland, it was found that young adults (16 to 40 years old) and 
women have a higher incidence of strokes on weekends and holidays, especially during 
the evening hours (Haapaniemi 1996).  A systematic review (Guiraud 2010) also 
identified binge alcohol abuse of 40 to 60 grams within the preceding 24 hours or >150 
grams within the preceding week to increase the risk of stroke (odds ratio 2.66, 95% CI 
1.54-4.61 and 2.47, 95% CI 1.52-4.02).  Other putative risk factors for triggering a stroke 
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event included anger, heavy eating, negative or positive emotions, sudden postural 
change in response to startle, and psychological distress (Guiraud 2010).   
Social circumstances beyond socioeconomic status may also affect risk of stroke.  A 
study of 22,818 individuals over 50 years old in the Health and Retirement Study in the 
U.S.A. found the highest risk of stroke among widowed men (hazard ratio 1.40, 95% CI 
1.12-1.74 compared to married women).  Low income and lack of wealth were associated 
with stroke incidence in married and unmarried women and men, but unmarried women 
had the highest risk of all groups when affected by low income (Maselko 2009). Parity 
may also influence the risk of ischemic and hemorrhagic stroke.  In the Shanghai 
Women’s Health Study (SWHS), stroke prevalence increased with increasing number of 
children in both women and men, including after adjustment for socioeconomic status 
and other potential confounders (Zhang 2009). A separate study (Skilton 2009) found that 
a higher number of children is associated with increased carotid atherosclerosis in women 
but not men.  The authors concluded that childbearing and not childrearing may be a risk 
factor for atherosclerosis.  In Korea, each additional pregnancy increased the risk of 
hemorrhagic stroke in women, including intracerebral hemorrhage and subarachnoid 
hemorrhage when studied separately (Jung 2010).  A relationship between stroke 
mortality and parity was not found after adjustment for socioeconomic status in Norway 
(Jacobsen 2011). Importantly, risk factors for stroke, such as obesity and smoking, may 
be shared in social networks beyond the influence of neighborhoods and location 
(Christakis 2007).  
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A population-based case–control study of 1250 stroke deaths in rural Bangladesh 
 
Introduction 
In 2008, cerebrovascular disease was ranked as the second most common cause of death 
globally, accounting for 6.2 million of the 57 million deaths that occurred (World Health 
Organization 2008). Stroke is an increasing burden of disease and leading cause of death 
in least developed countries, but population studies are lacking. People of Bangladeshi 
origin who have emigrated to the United Kingdom experience persistent and substantial 
inequalities in stroke mortality compared with the age matched UK population (Wild 
2007). The possibilities for this excess risk are poorly understood and may include higher 
rates of uncontrolled hypertension, chronic inflammation, vitamin D deficiency, betel nut 
consumption, and squatting and straining at stool (Bhopal 2005). Studies on the risk of 
stroke in Bangladeshis in Bangladesh are limited. A study of more than 15 000 people 
during a door-to-door survey found the prevalence of stroke above the age of 40 years to 
be three per 1000 adults. There were more strokes in men than in women and in rural 
compared with urban areas (Mohammad 2011). In a hospital-based study in Chittagong, 
patients with stroke had high rates of hypertension (59%), ischemic heart 
disease (19%), and dyslipidemia (11%) (Mollah 2007). In Mymensingh, 66% of 
hospitalized stroke patients had a known diagnosis of hypertension and 63% were 




Although stroke may be a major cause of death in rural Bangladesh, little population-
based data on the underlying prevalence of risk factors and attributable mortality are 
available. A health and demographic surveillance system (HDSS) site has been used to 
monitor birth, migration, and all-cause mortality in rural Bangladesh since 1966. Over a 
recent 4-year period, there have been more than 1000 deaths attributed to stroke at this 
site. Here we analyze data from a population-based mortality surveillance site in rural 
Bangladesh to (i) determine the burden of fatal stroke in a least developed country and 





The institutional review board at ICDDR, B approved the collection of verbal autopsy 
data at Matlab, Bangladesh. The Johns Hopkins University Bloomberg School of Public 
Health Institutional Review Board deemed the protocol for reporting the de-identified 
verbal autopsy data exempt from further review. 
 
Study design and subjects 
 
A HDSS site operates in Matlab, Bangladesh, 55 km southwest of the capital city, Dhaka. 
Matlab had an average of 223 886 people living in 142 villages in 2008 (ICDDR, B 
2009). Verbal autopsy, an interview-based method to determine the cause distribution of 
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deaths in a population, is performed following every death of a Matlab resident. During a 
verbal autopsy, family members and close contacts are asked about the symptoms and 
health status of the deceased prior to the time of death. To participate, the person who 
reports to the interviewer must be (i) closely related to the deceased, (ii) present 
during the illness that led to death, and (iii) able to describe the illness symptoms and 
medical consultations prior to death. A series of standard questions on a validated survey 
instrument were asked by trained, nonmedical community-level interviewers. The current 
survey used in Matlab was developed by the World Health Organization and modified by 
the INDEPTH Network for use in multiple surveillance sites in 2003 (Alam 2010). The 
10th edition of the International Disease Classification (ICD) was employed at that time. 
The cause of death for an individual was assigned by medical officers who reviewed the 
questionnaire responses. A standard diagnostic code was listed as the primary cause of 
death, based on the first three digits of the ICD-10 code. All causes of death are 
monitored in this way, although the traditional use of this data has been for the 
surveillance of maternal and early childhood deaths. Previous evaluation of the 
monitoring of deaths by verbal autopsy in Matlab found that 99.9% of all deaths are 
recorded by verbal autopsy and 90% of all deaths occur at home (Alam 2010). 
 
Amongst deceased persons with an ICD-10 diagnosis of stroke, demographic and clinical 
information, including sex, education level, occupation, coexistent illnesses including 
diabetes, hypertension, habitual use of various forms of tobacco (cigarette smoking/biri, 
pipe smoking/hookah, tobacco powder/gool, and betel), coronary heart disease, location 
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of death, and month and age at death, were recorded. All information on comorbidities 
and cause of death were derived from the verbal autopsy questionnaire and narratives. No 
medical records of the decedents who sought care were reviewed for this study. Only 





All stroke deaths from 1 January 2005 through 31 December 2008 were included in this 
analysis and compared with all adult injury deaths. Adult injury deaths were used as 
controls because they represented a large number of adult deaths in this population that 
could not be attributed to traditional vascular risk factors. 
 
Risk factors for stroke versus injury deaths were assessed using a multivariable logistic 
regression model, adjusting for age and sex. Confidence intervals for odds ratios were 
obtained by inverting a profile likelihood ratio test statistic (Venables 2002). The 
distribution of given characteristics or risk factors amongst several subgroups was 
compared using a Pearson’s chi-square test. An estimate of the proportional mortality 
because of stroke in the population was obtained using the relationship:  
 




where sensitivity and specificity refer to the verbal autopsy instrument for stroke, 
prevalence is the proportional mortality of stroke, and probability of a positive test is the 
proportion of deaths in the population of interest deemed to be because of stroke by this 
same instrument. Unrecorded measurements were assumed to be missing completely at 
random. The programming language R (R for Mac OS X GUI 1.35; R Foundation for 
Statistical Computing, Vienna, Austria) was used to conduct all analyses. All tests of 
hypotheses were performed under two-sided alternatives at confidence level 0.95. 
Results 
There were 1250 deaths because of stroke and 246 deaths because of unintentional injury. 
1250 stroke deaths occurred of 4870 total adult deaths (population attributable mortality 
25.2%) (Table 1). The baseline characteristics of people with stroke were compared with 
those who died of unintentional injuries (Table 2). Unintentional injury deaths in this 
population were most often because of falls (25.2% of all injury deaths), drowning 
(15.5%), train or road accident (12.7%), and acid burns (9.5%). 
People who died of stroke had a higher mean age. Likely due to older age, people who 
died of stroke were also less likely to have received a formal education. More than 90% 
of stroke deaths occurred at home. Potential risk factors for stroke death were compared 
between women and men in Table 3. Men who died of stroke were significantly more 
likely to have diabetes, smoke cigarettes, consume betel, and have attained a higher 
education than women. There were more strokes in winter (December to March) than 
summer (June to September) (P < 0.001) (Figure 1). The multivariable logistic regression 
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model for risk of stroke death is presented in Table 4. There were 1140 betel chewers in 
this study, including 1053 who died of stroke. Overall, there were 403 people who 
chewed betel and smoked cigarettes (n = 377 stroke deaths, n = 26 injury deaths), 733 
who only chewed betel (n = 672 stroke, n = 61 injury), 111 who only smoked cigarettes 
(n = 98 stroke, n = 13 injury), 132 who used neither betel nor cigarettes (n = 99 stroke, n 
= 33 injury), and 145 with incomplete data on betel use and/or smoking. Using published 
sensitivity (81.5%) and specificity (93.6%) of a similar verbal autopsy instrument, 
validated in Chinese adult deaths (Yang 2006), with the equation depicted earlier, the 




This large, population-based study from a rural, resource-limited setting captured a high 
number of stroke deaths. Although modifiable risk factors for stroke are generally 
overlooked in least developed countries, many of which are experiencing the late stages 
of the epidemiological transition, they represent a significant, remediable, and potentially 
preventable burden of disease. Approximately 40% of all stroke deaths occurred in 
persons <60 years old in rural Bangladesh in this study, making stroke in the younger 
adult a particularly important target for health services intervention. In contrast to the 
high need, a recent survey (Bleich 2011) found just 11 non-governmental organizations 
address noncommunicable diseases in Bangladesh, including 2 that include a focus on 
cardiovascular disease and none on stroke. There is also no emergency thrombolysis for 




Our study emphasizes the potentially high burden of hypertension in the rural 
Bangladeshi population and its important contribution to fatal stroke death in men and 
women. In the Bangladeshi population in general, rates of hypertension and risk of 
diabetes are high (Zaman 1999, Zaman 2001, Sayeed 2002, Bangladesh NCD Risk Factor 
Survey 2010), portending a high stroke burden in the coming years. The prevalence of 
systolic hypertension in Bangladesh ranges from 9 to 18% in reported studies (Zaman 
1999, Sayeed 2002). One study of 2361 native Bangladeshis in the year 2000 found that 
14% of people over 20 years old had systolic hypertension and 9% had diastolic 
hypertension (Bangladesh NCD Risk Factor Survey 2010). A more recent study in 2009–
2010 reported 17.9% of 9275 adults over 25 years old had hypertension (Sayeed 2002). 
The prevalence of hypertension at this study site and surrounding regions has been 
previously reported to be 12% amongst adults of age 25 years and older, with 40% of 
diagnoses made by unqualified medical providers (Khanam 2011). Younger patient age, 
lower levels of formal education, and diagnosis by an unqualified provider were related 
to antihypertensive medication non-adherence (Khanam 2011). Although not specifically 
studied in this population, arsenic exposure has also been proposed as a trigger for 
hypertension amongst well-water drinkers in rural Bangladesh (Rahman 1999). Diabetes 
also accounts for a significant burden of disease and was a risk factor for fatal stroke in 
this study. In rural Mymensingh district, systematic measurements of blood glucose in 
4923 subjects over 20 years old revealed that 3.8% had diabetes and 13.0% had impaired 
fasting glucose (Sayeed 2003). Our findings are likely generalizable to other populations 
studied in the Indian subcontinent who have a high prevalence of hypertension and 
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diabetes, including Nepal (34% hypertension, 6% diabetes) (Sharma 2011), Sri Lanka 
(19% hypertension, 14% diabetes, 14% impaired fasting glucose) (Wijewardene 2005) 
and India (ranging from 21 to 36% for hypertension, 35% diabetes) (Singh 2011, Gupta 
2011, Kaur 2011, Joshi 2012). Seasonality is also a potential contributor to fatal stroke 
incidence. One study in a referral hospital in Bangladesh found a significantly higher rate 
of ischemic stroke in summer compared with winter months (Hannan 2001). This study 
demonstrates the opposite trend: fatal stroke incidence was higher in the winter months. 
The reasons for this finding are unclear, and literature from other countries 
(Klimaszewska 2007) in which colder weather is correlated with vascular events cannot 
be easily generalized to this setting where winter months are still relatively warm. 
We have also identified habitual betel nut consumption as a potential independent risk 
factor for fatal stroke. Betel nut, derived from the palm tree Areca catechu, is regularly 
chewed by at least 10% of the world’s population (Boucher 2002). It is considered the 
fourth most common addictive substance in the world and consumed in various ways, 
including raw, baked, or dried, in a preparation that may involve betel leaf, Piper vine, or 
lime paste, usually combined with tobacco. Betel consumption is common in the Indian 
subcontinent, China, Southeast Asia, and the South Pacific islands where it is used as a 
stimulant, to aid digestion, and in social settings (Chu 2002). The International Agency 
for Research on Cancer (IARC) recognizes betel nut as a carcinogen (World Health 
Organization International Agency for Research on Cancer 2007). Recently, betel nut has 
been associated with an increased risk of cardiovascular disease (Hung 1998, Guh 2007, 
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Lin 2008, Zhang 2010, Tseng 2011), but there are few comparable studies that consider 
stroke (Wen 2005, Lan 2007). 
 
In a prospective cohort study, The Survey of Health and Living Status of the Near Elderly 
and Elderly in Taiwan, past or current betel nut chewing increased the risk of stroke death 
in individuals aged 50 years and older (hazard ratio 1.66, 95% CI 1.19–2.30) (Lan 2007). 
However, only 14% of the cohort had ever chewed betel nut and they accounted for just 
51 stroke deaths. In a separate Taiwanese study in 2001, based on the National Health 
Interview Survey, the relative risk of stroke death amongst betel chewers was 1.3 (95% 
CI 0.8–2.2). There were 22 stroke deaths amongst betel chewers, all 
of whom also smoked tobacco. In the present study, 76% of people chewed betel nut 
including 91% of women and 77% of men who died of stroke. Possible mechanisms of 
betel nut include a parasympathetic response from arecoline, the major constituent 
alkaloid. 
 
Arecoline and guvacoline become hydrolyzed to arecaidine and guvacine when mixed 
with lime and can inhibit uptake of GABA (Johnston 1975). Betel leaf, used to envelope 
the nut or paste, contains aromatic phenols that stimulate catecholamine release in vitro. 
Importantly, the effect of betel nut on stroke may be partially mediated through obesity 




This study has limitations. The verbal autopsy instrument used in the diagnosis of stroke 
at this HDSS site, like many verbal autopsy instruments, has not been validated. There is 
a possibility of misclassification error in determining stroke deaths. Key responses 
including sudden onset paralysis, involvement of one half of the body, and lack of fever, 
for example, were used to make the diagnosis; however, imaging studies were not 
performed, and most deaths occurred outside of healthcare facilities. The distribution of 
hemorrhagic versus ischemic strokes is unknown. Even if imaging was available in 
healthcare facilities, the high number of in-home deaths in Matlab suggests that a 
population-based assessment for stroke could not justifiably be made using healthcare 
facility information. Although some of the cases may have been seen at a health facility 
where they were diagnosed by a physician and returned home before death, this is likely a 
small number of the total cases.  Previous studies of verbal autopsy instrument validation 
specifically considering adult deaths reported that even though sensitivity for a cause of 
death in an individual is often modest, the population estimations of cause-specific 
mortality ultimately exhibit little distortion because of compensatory patterns of 
misclassification (Yang 2006). In our study, the verbal autopsy method appeared to 
overestimate the true proportional mortality because of stroke when comparing the 
population-attributable mortality to the calculated prevalence using the sensitivity and 
specificity of a similar instrument (25.2% vs. 17.2%). This is possibly because it is more 
common for other causes of death, such as chronic obstructive pulmonary disease, to be 
classified as a stroke death than for a stroke death to be classified as another etiology 
(Yang 2006). Important risk factor data on body mass index, dyslipidemia, and alcohol 
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use were not completely available in this population, but are important areas of further 
study and refinement of existing verbal autopsy instruments for chronic disease. 
Hypertension may have been underestimated in this group, and validation studies are 
required for future studies.  
 
Compared with published data on the prevalence of hypertension in combined fatal and 
non-fatal acute stroke, our reported rate of hypertension in fatal stroke (47%) is lower 
than expected from internationally derived data (66% ischemic stroke, 83% hemorrhagic 
stroke) (O’Donnell 2010). Family history of vascular deaths is not collected in Matlab, 
but may be less useful in Bangladeshis whose parents experienced low life expectancy 
over the past generation (56 years old for men and 54 years old for women in 1978) [8]. 
The amount and duration of betel consumption was not asked, although other studies of 
betel chewers have found that a quarter of consumers of betel nut chew the preparation 
more than 10 times per day (Guh 2007), 85% of chewers chew daily (Yen 2006), and 
betel cessation is uncommon (Hung 1998). Also, the control group of people who died of 
unintentional injuries in this study was relatively smaller and younger. Age and sex were 
adjusted for in all regression analyses; however, assumptions were made that age could 
be properly adjusted for in a regression model. Although imperfect, the control group of 
adult injury deaths was chosen because of both the high number of total deaths in the 
study timeframe and the expectation that it was least likely to have vascular risk factors 
as a contributing cause of death. There was no more suitable population as other major 
causes could be affected by the same risk factors. Global estimates on the burden of 
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stroke are inferred through disease modeling, many times based on verbal autopsy as, 
worldwide, the vast majority of all deaths are uncounted. Although imperfect, verbal 
autopsy can provide foundational data in regions where the putative population-
attributable mortality from stroke and other neurological diseases is unknown. These 
otherwise silent deaths can inform policy on the burden of stroke and its important risk 
factors in some of the world’s poorest regions. 
 
 
Long-term Predictive Value of the Framingham Risk Score for Stroke in HIV-
infected versus HIV-uninfected Men: The Multi-Center AIDS Cohort Study   
 
Introduction 
The Framingham Risk Score for Stroke (FRS-S) was developed in the early 1990s to 
identify individuals at substantially increased long term stroke risk.  The score provided 
impetus for risk factor modification and drew attention to individuals who were at risk of 
stroke due to borderline levels of multiple factors (Wolf 1991).  In the early 1990s, 
survival of people with HIV infection was limited, and the Framingham Heart Study 
Offspring Cohort, in whom the FRS-S was developed, was not tested for HIV serostatus.   
With the advent of highly active antiretroviral therapy (HAART) and longer survival of 
HIV+ individuals, the relationship between chronic HIV infection, HAART use, and 
vascular disease has become increasingly important (Friis-Møller 2010, Hasse 2011, 
Rasmussen 2011, Benjamin 2012, Cruse 2012).  The influence of HIV on long-term 
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stroke risk remains unresolved (Berger 1990, Cole 2004, Corral 2009, Ovbiagele 2011, 
Mateen 2012) even though more than half of all prevalent HIV cases in the U.S. will be 
more than 50 years old by the year 2015 (Centers for Disease Control and Prevention 
2011).  Longitudinal studies that prospectively ascertain the effect of HIV on stroke risk 
in the HAART era are not reported (Benjamin 2012). 
Here we test the long-term predictive value of the FRS-S in a large, prospectively 
followed cohort of HIV-infected (HIV+) versus uninfected (HIV-) men who have sex 
with men (MSM) in four U.S. cities.  First, we compare the baseline characteristics of the 
Framingham cohort versus the MACS participants for important stroke risk factor 
differences. Second, we report the stroke incidence in HIV+ and HIV- men and 
determine whether the FRS-S, ten years earlier, differed by HIV serostatus, among 
participants with strokes. Finally, as a separate analysis, we calculate the FRS-S at the 
beginning of the HAART era for all MACS participants and compare it between HIV+ 
and HIV- groups.   
Methods 
The MACS was approved by the Institutional Review Board at each study site. Each 
participant provided his own informed consent to participate in the MACS.  Analysis of 




The MACS began in 1984 to study the natural history of AIDS.  The enrolment, 
recruitment, and goals of the MACS have been reported (Kaslow 1987, Detels 2012).  
MSM were recruited in Baltimore, Chicago, Los Angeles, and Pittsburgh.  Cumulative 
enrolment is now at >7000 participants.  MSM were chosen because they represented a 
group at high risk for AIDS and could reliably participate in a longitudinal follow up 
study. The HIV status of the men at enrolment was unknown.  MSM who remained HIV- 
serve as a comparison group in the present study.  
MACS participants are followed every 6 months via standardized in-person interviews, 
clinical assessments, neuropsychological screening tests, and laboratory evaluation, 
including measurements of HIV viral load and T-cell subsets (Roche ultrasensitive assay, 
<50 copies/mL), and standardized and quality-controlled flow cytometry) (Kaslow 1987).  
By late 1996, HAART was initiated by >50% of all participants, which is considered here 
as the beginning of the HAART era (Jacobson 2002). Stroke events that occurred over a 
15-year period of the HAART era (July 1, 1996-June 30, 2011) were used in this 
analysis.   
 
Definition of Stroke 
Stroke was ascertained by either self-report at the study visit, prospective active reporting 
by participants between visits, review of causes of death, or ad-hoc when reviewing 
medical records to confirm other diagnoses.  At each MACS visit, participants were 
asked whether they were diagnosed with stroke since their last visit, and, in April 2004 
through March 2005, they were asked about lifetime history of stroke.  In addition, 
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reasons for any hospitalization are reviewed as well as other diagnoses found by visits to 
doctors for vascular or neurologic problems. These reported events are recorded using the 
International Classification of Disease 9th edition codes.  Reported strokes were followed 
up by each study site’s investigators, including neurologists, via correspondence to the 
participant’s physician.  Death of MACS participants is continuously monitored. For 
deaths that were reported by participant contact (e.g., next-of-kin, partner, physician), 
death certificates were ascertained and systematically searched for the diagnosis of 
stroke. Deaths in the MACS are also captured and verified via the National Death Index, 
Social Security Death Index, credit databases, and scanning of obituaries. Medical 
records prior to death were requested. Fatal stroke was defined as a stroke with a reported 
death within 30 days after the date of first presentation of stroke.  Death events were 
provided on the death certificate of the participant.   
Any event that fit the definition of “silent stroke,” defined as imaging findings 
representative of stroke that were not correlated with clinical symptoms of stroke, were 
excluded.   Self-reported stroke events that could not be confirmed were included, and 
sensitivity analyses were performed (Table 5).  
Framingham Risk Score for Stroke 
The original FRS-S score was sex-specific and based on 36 calendar years of follow up 
of 2372 men and 3362 women aged 55 to 84 years old (Wolf 1991). There were 213 
strokes in men and 259 strokes in women in the Framingham Heart Study’s original 
cohort from whom the FRS-S was derived.  The distribution of events diagnosed in men 
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was atherothrombotic brain infarction (46%), transient ischemic attack only (24%), 
cerebral embolus (19%), intracerebral hemorrhage (5%), subarachnoid hemorrhage 
(4%), and other (2%).   Points for sex-specific FRS-S were ascribed based on eight 
baseline risk factors, identified via Cox proportional hazards regression models: age, 
systolic blood pressure (mmHg), antihypertensive therapy, diabetes mellitus, cigarette 
smoking, atrial fibrillation on electrocardiogram, left ventricular hypertrophy on 
electrocardiogram, and history of previously diagnosed cardiovascular disease (Table 6).  
Cardiovascular disease in the original score included coronary heart disease, history of 
myocardial infarction, angina pectoris, coronary insufficiency, cardiac failure, and 
intermittent claudication.   
Vascular Risk Factor Definitions 
In the MACS, risk factors for stroke were defined according to the Framingham Study 
whenever possible.  For participants who were less than 55 years old, the number of 
points ascribed for age as a risk factor was zero.  Diabetes mellitus was defined here, 
based on updated recommendations, and previous reports from the MACS as either (1) 
measured fasting glucose levels ≥126mg/dL, (2) measured nonfasting glucose levels 
≥200 mg/dL when fasting samples are unavailable, or (3) self-reported diagnosis of 
diabetes treated with medications.  Diabetes was ascertained at study entry and during 
regular study visits after April 1, 1999.  Cigarette smokers are defined here as current 
smokers.  Consistent with the FRS-S, former cigarette smokers were not given risk points 
in the risk assessment.  Specific cardiac conditions used in the original FRS, were not 
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regularly evaluated clinically by MACS investigators.  Electrocardiograms were also not 
performed as part of the MACS.  It was assumed here that no MACS participants had 
atrial fibrillation or left ventricular hypertrophy; therefore, no MACS participants 
received points for these conditions on the FRS-S in this analysis.  However, within the 
MACS, participants were asked to report their lifetime history between April 2004 and 
March 2005 - and follow up information on subsequent visits - on whether or not they 
had experienced: (1) myocardial infarction, (2) angina or chest pain caused by the heart, 
and (3) congestive heart failure.  Participants who responded affirmatively to these 
questions were ascribed the 3 points for cardiovascular disease defined in the FRS-S 
(Table 6).  All other participants were ascribed zero points.  The FRS-S risk score 
conversion to the 10-year predicted risk of stroke is based on the percentage points 
derived from the original Framingham cohort (Wolf 1991). 
Statistical Analysis 
Participants with prevalent stroke at the time of study entry or stroke in the pre-HAART 
era were excluded. Among participants with a first-ever stroke during the HAART era, 
FRS was calculated using risk factors and characteristics from the study visit closest to 10 
years prior to the date of the stroke event. The algorithm provided by the FRS cohort was 
employed to ascribe points (Table 6). Ten-year predicted probability of stroke was based 
on the original Framingham study (Wolf 1991). Participants in whom risk factor 
information was missing were considered not to have the risk factor of interest.   
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As a second measure of stroke risk, calculation of the baseline FRS-S among the entire 
MACS cohort was performed and compared between HIV+ and HIV- participants.  This 
was done on all MACS participants, whether they had a stroke event or not, and 
calculated at the beginning of HAART era (1 July 1996) or, if the participant entered the 
MACS afterwards, at the participant’s first date of study entry in the HAART era.    
Comparison between groups was performed using the Wilcoxon-Rank sum tests and two-
sample binomial tests for proportions. To reconstruct the FRS-S in the MACS, Cox 
proportional hazards models were both employed, stratified by serostatus and combined 
using serostatus as a binary predictor. The date of data censoring was death of the 
participant, study drop-out by the participant, or the last follow up visit on or before June 
30, 2011.    
Results 
There were 3945 participants (1776 HIV+, 2169 HIV-) in MACS during the study 
timeframe.  The baseline characteristics of this cohort and incidence of all neurological 
disease have been reported7 and are provided by stroke and HIV serostatus in Table 7.  
There were 114 strokes in MACS participants recorded, including 19 fatal strokes among 
HIV+ participants (n=12) and HIV- participants (n=7).  The stroke events occurred 
throughout the study observation period (Figure 2). 
There were 94 first-ever strokes among 57 HIV+ and 37 HIV- participants with an 
incidence rate of first-ever stroke of 1.7/1000 person-years in HIV- and 3.3/1000 person-
years in HIV+ participants (Table 7).  The median age at the time of first stroke diagnosis 
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was 55.6 years (range 34.5-8.5 years old).  Among HIV+ participants, the median age of 
first stroke was 51.4 compared to 61.8 years in HIV- participants (p<0.0001).  A total of 
70 (74%) were enrolled in the MACS for 10 years or more prior to their first stroke event.   
Among HIV+ participants with first-ever stroke, 52 (91%) occurred while the participant 
was taking HAART.  CD4 count within 60 days prior to the stroke event was available 
for 42 of the 57 HIV+ participants with stroke (mean 484 cells/mL, range 17-1256).  
Among this group, 8 had a CD4 count <200 cells/mL of whom 7 reported being on 
HAART.  
For HIV+ participants with stroke, the FRS-S 10 years prior to stroke event, for 10-year 
prediction of stroke, averaged 4.9% (range 0-15%) compared to HIV- participants with 
stroke whose baseline FRS-S averaged 6.6% (range 3-26%) (p<0.04).  When considering 
only the subgroup of MACS participants who were enrolled in the cohort study for 10 
years or longer, the difference in mean FRS-S between HIV+ and HIV- participants was 
still significant (4.0% vs. 5.9%, p<0.02).  Notably, three HIV+ participants with strokes 
and more than 10 years of follow up had a FRS-S predicted risk of zero.  
The distribution of risk factors for HIV+ and HIV- men with stroke events is reported in 
Figure 3. Points are given according to the original FRS.  Overall, HIV+ participants 
were more likely to be younger and smoke cigarettes.  HIV- participants were marginally 
more likely to have hypertension.  The distribution of history of diabetes and history of 
myocardial infarction was similar between HIV+ and HIV- men with strokes.  
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In the entire cohort of HIV+ men who did not experience a stroke (median and mean age 
at first visit during the HAART era 41 years), the mean 10-year predicted risk of stroke 
was 4.11% (range 0-26%) versus 4.05% (0-22%) in HIV- men (median and mean age 43) 
(p<0.02).  In participants without known stroke events, hypertension and cigarette 
smoking were more likely among HIV+ men (Figure 4).    
In the analysis of baseline stroke prediction, the association between stroke and 
traditionally measured risk factors in the FRS-S was similar between the Framingham 
cohort participants and the MACS participants but there was a significant added risk of 
HIV status among HIV+ MACS participants (p<0.0001, Table 8). 
Discussion 
Several studies have suggested an increased risk of stroke in HIV+ adults (Evers 2003, 
Cole 2004, Corral 2009, Rasmussen 2011, Chow 2012, Vinikoor 2013), but prospectively 
followed HIV+ individuals over 10 years or more with incident stroke have not 
previously been available.  Many studies of HIV+ adults are limited to small numbers of 
stroke events (Hoffmann 2000, Mochan 2003, Evers 2003, Cole 2004, Corral 2009) and 
none have had the opportunity to compare baseline risk with long-term incidence of 
stroke.  The comparison of baseline risk and long-term outcome remains of critical 
importance to HIV+ individuals.  Traditional scores for risk prediction appear to be 
insufficient to accurately inform long-term cerebrovascular health status in chronic HIV 
infection.  We observed a higher incidence of first-ever strokes in HIV+ versus HIV- 
participants (3.3 versus 1.7/1000 person years); however, the average 10-year FRS-S 
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predicted risk at baseline was lower in HIV+ versus HIV- subjects (4.9% versus 6.6%). 
Remodeling of the baseline stroke risk in the MACS demonstrates that HIV adds a 
significant risk of stroke.  
There are several reasons that the FRS-S may have underestimated stroke risk in HIV+ 
men in this study.  Risk difference using the FRS-S between HIV+ and HIV- men may be 
partly accounted for by the younger onset of stroke in HIV+ men therefore leading to 
lower FRS-S point calculation at 10 years prior to the event.  The original FRS-S was 
designed in men aged 55 to 84 years old and was not modeled for young-onset stroke 
prediction.  In the current study, the median age for stroke was in the fifth and sixth 
decades of life for both HIV+ and HIV- MSM.   
HIV+ individuals may have unique risk factors for stroke that are measurable and can 
therefore lead to adjustment in their FRS-S.  One study from Spain found that high 
alcohol intake, a history of a diagnosis of AIDS, and fewer months on HAART increased 
the risk of stroke, although only 25 patients with stroke were identified (Corral 2009).  
HIV infection itself may portend a higher stroke risk, even when accounting for 
demographic and traditional stroke risk factors. A U.S. study found that HIV remained an 
independent predictor for stroke when comparing HIV+ versus HIV- individuals from 
different cohorts even after adjustment for known risk factors.  Most others in high 
income settings suggest that HIV increases stroke risk (Table 9) (Hoffmann 2000, Evers 
2003, Mochan 2003, Cole 2004, Patel 2005, Ortiz 2007, Tipping 2007, Corral 2009, 
Lifson 2010, Rasmussen 2011, Chow 2012, Vinikoor 2013).  In South Africa, however, 
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most studies report similarities in patient characteristics and stroke incidence between 
HIV+ and HIV- groups (Hoffman 2000, Mochan 2003, Patel 2005). 
The reasons for increased rates of stroke among HIV+ men could include such 
mechanisms as chronic inflammation leading to atherogenic tendency of the endothelium, 
remodeling of the intracranial and carotid vasculature, and higher frequency of 
circulating inflammatory markers (Ortiz 2007, Seaberg 2010, Falcone 2011, Sen 2012).  
In the multinational STACCATO study (Calmy 2009), inflammatory markers associated 
with increased cardiovascular risk, such as soluble vascular adhesion molecule-1 
(sVCAM-1), were associated with HIV RNA replication and decreased with HAART 
initiation.  In a separate study by the SMART/INSIGHT and D.A.D. working groups 
(Calmy 2009), Abacavir, found in some HAART regimens, was associated with an 
increased risk of all-cause cardiovascular disease which included stroke.  The relationship 
between HAART and longterm stroke risk in general requires further investigation since 
typical antiretroviral treatment has changed over time. 
There may also be important risk factors that confound the relationship between stroke 
and HIV such as injection drug abuse with cocaine, excessive alcohol use, or poor 
medication adherence.  Given that the majority of the HIV+ cohort with strokes was 
HAART-treated, it is unlikely that the stroke were caused by opportunistic infections; 
however, a fraction of the HIV+ participants with stroke had lower than expected CD4 
counts and should be considered immunosuppressed.  The MACS represents mostly 
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HAART-treated adults, a situation that almost certainly mimics the clinical scenario in 
most high-income settings.  
Our study had several limitations.  Stroke ascertainment in this cohort was partially 
dependent on self-reported events that were later verified by physicians and study 
investigators.  In some cases, medical records from the patient could not be verified by 
the study site and diagnosis could only be based on the participant’s provided 
information.  Although a majority of strokes received an ICD-9 designation by the 
treating physician, there were several events that were not sub-classified by mechanism 
or stroke type.  We are unable to report the number of strokes by subtype and compare 
them to the original Framingham Heart Study cohort; nonetheless, the FRS-S is useful for 
general risk of stroke and not specific to subtype.  Assessments related to stroke severity, 
functional outcome, and neuroimaging confirmation were not consistently available in 
the MACS.  This is true in most study cohorts of HIV+ individuals in whom vascular 
disease, particularly stroke, was not a priority condition to study.  Since MACS began 
studying self-reported strokes in detail in 2006, it is possible that strokes that occurred 
earlier in the HAART era were not all ascertained.  However, given our definition of the 
HAART era as 1996 and beyond, the inclusion of stroke in 2006 on interview forms is 
however still appropriate for assessment of risk at the required time point of 10 years 
earlier.   
Some MACS participants had a stroke event prior to 2006, and pre-HAART era years 
were included in their risk period.  This occurred in a minority of cases.  Diabetes 
40 
 
mellitus was ascertained regularly from April 1999 onwards and at the time of the 
participant’s study entry into the MACS.  Notably, a participant who developed diabetes 
between his study entry and April 1999 may not have the date of diabetes diagnosis 
recorded with the MACS cohort until 1999.  This would lead to under-estimation of his 
FRS-S, since points would not have been ascribed for diabetes in that individual in that 
timeframe.  
Our study was limited to adult MSM.  It is possible that our findings are not generalizable 
to other HIV+ populations such as women, ethnic minorities, or persons with other high-
risk behaviors for stroke such as injection drug abuse. There are more African Americans 
in the MACS compared to the Framingham Heart Study which may lead to a differing 
baseline risk of stroke. Race is not part of the FRS-S but has been studied in 
cardiovascular disease prediction (D’Agostino 2001). Also, access to care may be better 
among MACS participants compared to other populations at risk.  
This study had several strengths.  The MACS has the advantage of enrollment of both 
HIV+ and HIV- MSM in the same prospective cohort study and does not derive its 
control group from other databases or registries.  Many other cohorts lack an HIV- 
control group, making it difficult to discern the relative contributions of age, other HIV-
related risk factors, and HIV infection.  The number of strokes in the MACS is amongst 
the highest of any HIV+ cohort with well-described cardiovascular risk factor variables 
and HIV status information. In spite of the high number of reports suggesting HIV is an 
important risk factor for stroke, the number of reported patients with both HIV and stroke 
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is small.   Other studies suffer from survival bias, such that an increased number of HIV+ 
individuals experiencing stroke in the HAART era may be inaccurately equated with HIV 
as a risk factor for stroke. In the MACS, we had the unique opportunity to retrospectively 
calculate the FRS-S in participants 10 years prior to stroke events. Since events were 
ascertained prospectively, there is no recall bias.  Also, our finding that some individuals 
with stroke had an FRS-S of zero suggests that there are particular individuals at high risk 
which is difficult to predict using standard scores. 
Adjustment and calibration of the FRS-S may be of high future utility in the HIV+ adult 
population.   Accurate information on stroke risk is especially important to the growing 
number of HIV+ adults with multiple comorbidities (Bergersen 2004, Kaplan 2007, Kim 
2012, Guiterrez 2013). Follow up of existing cohorts, with dedicated attention to vascular 
disease outcomes, is imperative to understand the accuracy of stroke prediction in HIV+ 
populations with various baseline risks. 
Arsenic Exposure and Carotid Artery Atherosclerosis:                                       
Prospective data from the Strong Heart Study 
Introduction 
Arsenic is one of the ten chemicals of major public health concern listed by the World 
Health Organization (WHO) (No authors listed. World Health Organization International 
Program on Chemical Safety 2014).  An established carcinogen, inorganic arsenic is most 
commonly ingested through drinking naturally contaminated groundwater, although 
exposure may also occur via food (rice and other grains), air pollution, smelting 
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operations and other occupational settings (Falk 2011, Jackson 2012, No authors listed. 
World Health Organization 2014). Increasing evidence supports the role of inorganic 
arsenic in a broad range of vascular diseases, particularly among populations exposed to 
levels above the WHO’s recommended upper limit in drinking water (10 μg/liter) (Chen 
2011, Moon 2013).   
Arsenic exposure has been postulated to be a risk factor for cardiovascular disease 
through its putative role in potentiating atherosclerosis (Engel 1994, Simeonova 2004).  
High-level arsenic exposures have also been linked to stroke (Moon 2012, Moon 2013), 
but the mechanism of stroke remains poorly understood.  Likely, a proximal source of 
thromboembolism is important for ischemic stroke occurrence in the setting of chronic 
arsenic exposure.  
Carotid intimal-medial thickness (CIMT) is an important direct risk factor for stroke 
(Bots 1997, Ebrahim 1999, O’Leary 1999).  CIMT is subclinical and increases 
progressively, serving as a biomarker of in vivo atherosclerosis.  Moreover, traditional 
vascular risk factors, such as hypertension and age, explain only a small degree of the 
risk of carotid atherosclerosis in reported studies (Rundek 2013).  This suggests that other 
risk factors may have an important etiological role in atherosclerotic plaque formation 
and progression in some populations, but these alternative risk factors remain mostly 
unexplored.    
One study in high-arsenic containing areas in Taiwan found a dose-dependent 
relationship between the number of years exposed to arsenic-containing well water and 
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later development of carotid atherosclerosis (Wang 2002). After adjustment for 
recognized cardiovascular risk factors, the odds ratio of carotid atherosclerosis (≥50% of 
intimal medial thickness) was 3.1 (95% CI 1.3 to 7.4) for people with a cumulative 
arsenic exposure of ≥20mg/L-years versus those without arsenic exposure from drinking 
well water.  However, individuated arsenic exposures were not available, and arsenic 
exposure times were estimated by history and duration of residence.  More recently, in 
Mexico, a study of 199 children found a positive association between higher 
concentrations of urinary inorganic arsenic and CIMT (0.058 mm per 1ng/mL in those 
with >70-ng/mL exposures) (Osorio-Yáñez 2013).  
In the Southwestern and Central United States, inorganic arsenic exposure through 
consumption of naturally contaminated groundwater has been a long-term concern and 
remains a problem in some rural communities, especially for families with private water 
wells.  Here, we examine the relationship between arsenic exposure and atherosclerotic 
plaque and CIMT in a large cohort of American Indians from the Southwest and Midwest 
of the United States.  We hypothesized that inorganic arsenic exposure is a risk factor for 
subclinical atherosclerosis of the common carotid arteries.   
Methods 
Ethics Approval 
The Indian Health Service, institutional review boards, and the participating tribes 
approved the study protocol.  Each participant provided his or her own consent to 
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participate in the Strong Heart Study.  Data analysis for this study was also approved by 
the Johns Hopkins University Institutional Review Board.  
Study Population 
The Strong Heart Study is a prospective cohort study designed in the 1980s, funded by 
the National Heart, Lung, and Blood Institute (NHLBI) to estimate cardiovascular 
morbidity and mortality in American Indians.   The Strong Heart Study was specifically 
designed to address a recognized lack of information on important risk factors for 
vascular diseases among American Indians in whom vascular diseases are a leading cause 
of death. Overall, 12 tribes in three geographic areas – Arizona, Oklahoma, and North 
and South Dakota, were represented in the study (Lee 1990). Targeted enrolment was 
1500 participants ages 45 to 74 years old in each of Oklahoma, Arizona, and North and 
South Dakota (Lee 1990, Weltry 1995). Cluster sampling was used for participant 
enrolment in North and South Dakota, whereas all tribal members in the selected 
communities in Oklahoma and Arizona were invited, either by telephone or letter.  Final 
enrolment in the Strong Heart Study was 4549 participants and the participation rate was 
62% (Stoddart 2009).  
Each participant underwent a structured interview, physical examination, anthropometric 
measurements, and collection of blood and urine specimens. The study observation 
period began at the date of the participant’s baseline study examination between 1989 
and 1991 in which urinary arsenic and other vascular risk factors were measured. For this 
study, the follow up was until study visit three (1998-1999) when 88% of all surviving 
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cohort participants were re-examined, including carotid ultrasound measurements.  We 
used data from 3,973 participants with sufficient urine available for arsenic 
measurements. We then excluded 1495 participants who did not participate in the carotid 
ultrasound measurement.  Subjects who did not undergo carotid ultrasound measurements 
were not different in terms of baseline risk of atherosclerosis compared to those who had 
the procedure performed (data not shown).  
Arsenic Measurements 
Arsenic exposure is through consumption of groundwater and well water contaminated 
by arsenic. Spot urine arsenic level was measured on a single occasion and is used as a 
proxy for arsenic exposure and arsenic internal dose. Arsenic measurements were 
performed on spot urine samples provided by participants at the baseline study visit 
(1989-1991).  Urine was collected in polypropylene tubes, frozen within 1 to 2 hours of 
collection, and transported on dry ice to long term storage at -70 degrees Celsius at the 
Penn Medical Laboratory (MedStar Research Institute, Washington DC, USA).  Urine 
arsenic measurements were performed on thawed samples, using up to 1 mL of urine in 
2007 (Trace Element Laboratory, Graz University, Austria).  Total arsenic concentration 
was measured using high-performance liquid chromatography/vapor generation 
inductively coupled plasma/mass spectrometry (Agilent 1100 HPLC and Agilent 7700x 
ICP-MS, Agilent Technologies, Santa Clara, California) (Scheer 2012).  In 2009, 
inorganic arsenic (arsenite, arsenate), monomethylarsonate (MMA) and 
dimethylarseninate (DMA) were measured in the participants’ baseline urine samples.  
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The concentration of arsenobetaine – a measure of seafood arsenicals - was very low, 
confirming that seafood consumption was low in this population, as expected (Moon 
2013).  As previously reported from a random sample of 380 adults in the Strong Heart 
Study, the interclass coefficient of combined inorganic and methylated arsenic species 
was 0.64 (95% confidence interval (CI) 0.60, 0.69), and the average change in urine 
arsenic concentration between study visits spanning ten years was -0.8 µg/g urine 
creatinine.  In general, DMA, MMA, and inorganic arsenic have half-lives of 
approximately 2, 9, and 38 days respectively (Pomroy 1980, Cullen 1989). To assess 
inorganic arsenic exposure in the present study, we used the sum of inorganic and 
methylated arsenic species, hereafter referred to as arsenic.  
Carotid Ultrasonography 
Imaging of the extracranial carotid arteries was performed using standardized protocols 
with centralized training of field sonographers. The participant was placed in the supine 
position with mild neck hyperextension in order to visualize the carotid bulb and 
extracranial internal and external carotid arteries (Roman 2012). Both carotid arteries 
were imaged using the Acuson 128 systems equipped with a 7 MHZ linear array arterial 
imaging transducer (The Strong Heart Study Operations Manual 2001).  Two-
dimensionally assisted M-mode tracings were obtained in tandem with electrocardiogram 
to achieve end-diastolic (maximal diameter) measurements of the common carotid 
arteries, approximately 1 centimeter caudal to the carotid bulb (The Strong Heart Study 
Operations Manual 2001, Roman 2012). Images were recorded on VHS videotape and 
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read at the Weill Cornell Medical Center’s Reading Center by an experienced 
cardiologist masked to the study question of interest.  Carotid measurements were made 
on stored images chosen from real-time videotapes using a frame-grabber computer 
software program (Imaging Technology, Woburn, MA) and high resolution (640 x 640-
pixel) video monitor (The Strong Heart Study Operations Manual 2001, Roman 2012). 
Three outcomes were measured on the carotid arteries.  The presence of atherosclerotic 
plaque was made based on carotid arterial wall thickening >50% compared to the 
thickness of the surrounding wall (Salonen 1988).  A carotid plaque score was calculated 
based on the number of segments containing plaque, combining left and right common 
carotid, carotid bulb, external and internal carotid artery zones (Hollander 2002). Carotid 
plaque score ranged from zero (no plaque in any segment in either artery) to eight.  Wall 
thickness was measured in the standard way, using electronic calipers, using the far 
carotid arterial wall at end-diastole, using several cycles on the taped video and averaged 
(Roman 2012). Wall thickness was never measured at the level of a plaque.  Left and 
right wall thicknesses were averaged and the mean thickness of the two (in millimeters) is 
used here.  
Other variables 
The laboratory and anthropometric measurements used in the Strong Heart Study have 
been previously reported in detail (Lee 1990, Weltry 1995).  The seventh report of the 
Joint National Committee on Prevention, Detection, and Evaluation, and Treatment of 
Hypertension definition of hypertension (Alberti 1998) was employed for hypertension: 
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systolic blood pressure ≥140 mmHg, diastolic blood pressure ≥90 mmHg, and/or the use 
of antihypertensive medications to treat blood pressure. Participants with values <140/90 
mmHg were deemed non-hypertensive.  Diabetes was based on the definition of the 
Provisional World Health Organization Report as fasting glucose ≥7.0mmol/L 
(126mg/dL), post-oral glucose challenge glucose measurement of  ≥11.1 mmol/L 
(200mg/dL), and/or the use of oral hypoglycemic medications or insulin to treat diabetes 
(The Seventh Report of the Joint National Committee on Prevention, Detection, 
Evaluation, and Treatment of High Blood Pressure 2004). Serum high- and low-density 
lipoproteins and triglycerides were measured in the fasting state at study baseline and 
treated as continuous variables (National Cholesterol Education Program 2002). 
Smoking was defined as current, past, or never in one’s lifetime. Past smoking was 
defined as having smoked at least 100 cigarettes but not currently smoking. Current 
smoking includes smoking currently and having smoked at least 100 cigarettes. Current 
alcohol use was defined as drinking regularly and having 12 alcoholic drinks or more in a 
lifetime.  Past alcohol use was defined as drinking regularly in the past, drinking 12 or 
more alcoholic drinks in the past, and not drinking alcohol within the previous year. Body 
mass index was defined in the standard way (kg/m2) (Garrow 1985). 
Statistical Analysis 
Continuous variables were described by their mean, standard deviation, median, range, 
and/or interquartile range. Categorical variables were summarized with frequencies and 
percentages. Urine arsenic was reported as the ratio of urine arsenic to urinary creatinine 
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to account for dilution in the spot samples.  Arsenic was right-skewed and log-
transformed for the analyses.  Then, this creatinine-corrected arsenic variable was divided 
by the natural logarithm of two so that each one-unit increase in the transformed arsenic 
variable represented a doubling of the urinary arsenic per creatinine value.  
 
After graphical display, mean CIMT was considered to be approximately normally 
distributed.  The association between mean CIMT and the variables of interest was 
analyzed using multiple linear regression.  The association between the presence or 
absence of atherosclerotic plaque and the variables of interest was analyzed using logistic 
regression. In the case of plaque score, the relationship between urinary arsenic and each 
score was assessed using ordinal logistic regression. Potential confounders of interest in 
all models were determined a priori based on previous knowledge and included smoking 
status (current, former, never), alcohol use (current, former, never), sex, and presence or 
absence of diabetes, as defined above. Continuous variables included systolic blood 
pressure (mmHg), waist-to-hip ratio, serum high density lipoprotein (HDL) (mg/dL), 
total cholesterol (mg/dL), and triglyceride level (mg/dL).  Analyses were also performed 
using the “atherogenic index” which is the log10 value of serum HDL divided by serum 
triglycerides but yielded no significant association on the outcomes of interest compared 
to using HDL and triglycerides as separate adjustment variables.  We also adjusted for 
geographic location (North and South Dakota, Arizona, or Oklahoma). All analyses were 





There were 2478 participants with measurements of both urine arsenic concentration and 
carotid artery endpoints. The carotid artery measurements from the total cohort are 
presented in Table 1, including CIMT of the left and right common carotid arteries, the 
average CIMT, presence of carotid artery plaque, and distribution of carotid plaque score.  
The distribution of characteristics of participants, by the presence or absence of 
atherosclerotic plaque in the common carotid artery, is provided in Table 2.  The 
prevalence of traditional cardiovascular risk factors was high: diabetes 45% and 
hypertension 31%, with a high average BMI 31.0 kg/m2 and waist-to-hip ratio was 0.948.   
Only 33% of participants never smoked cigarettes and 16% never drank alcohol.  
The mean arsenic concentration (µg per microgram creatinine) was 12.1 (SD 17.2) and 
median was 9.23 (25th and 75th percentiles of 5.62, 14.7).  The relationship between the 
risk factors of interest, including the sum of arsenic metabolites, and the mean difference 
in CIMT is found in Table 3.  In the complete model, adjusted for both behavioral and 
biological risk factors, older age, male sex, higher systolic blood pressure, lower high 
density lipoprotein (HDL), former vs. never smoking, current vs. never drinking alcohol, 
and higher waist-to-hip ratio as well as higher urine arsenic concentration were all 
independently associated with a statistically significant increase in the average CIMT.  
After adjusting for study center (model C in tables), the relationship between arsenic and 
CIMT and currently drinking alcohol both became non-statistically significant.   
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The relationship between these same risk factors and the absolute presence of 
atherosclerotic plaque is given in Table 13.  In this separate analysis, higher age, male 
versus female sex, higher systolic blood pressure, higher fasting blood glucose, presence 
of diabetes, current versus never smoking, current versus never drinking alcohol, higher 
total cholesterol, higher HDL, and higher BMI were all independently associated with the 
presence of atherosclerotic plaque. After adjustment for other recognized risk factors, 
there was no observed increased risk of carotid artery atherosclerotic plaque with 
increased levels of excreted creatinine-corrected urine arsenic. 
Carotid artery plaque score was grouped into the following categories: 0, 1, 2, 3, and 4 
and above given the smaller numbers of cases in the higher plaque score categories (as 
seen in Table 10).  The relationship between carotid artery plaque score and the risk 
factors of interest are provided in Table 5.  The relationship between score 0 and score 1 
is given and is approximately similar among the various strata as compared to score 0.  In 
this analysis of risk factors for higher carotid artery plaque score, higher age, male versus 
female sex, higher systolic blood pressure, higher fasting blood glucose, higher HDL, 
higher total cholesterol, higher atherogenic index, higher BMI, and current versus never 
smoking were all associated with a higher carotid plaque score.  As in the case of 
atherosclerotic plaque presence, there was no statistically significant association between 






In this prospective cohort of nearly 2,500 adults with low-to-moderate arsenic chronic 
exposure, an association between creatinine-corrected arsenic concentration and average 
CIMT was found; however, an association between arsenic and the presence and degree 
of common carotid artery plaque was not observed after adjustment for important 
behavioral and biological risk factors for vascular disease. Although other cohort studies 
have reported an association between CIMT and arsenic exposure, only one other study 
(Wang 2002) has reported on arsenic and carotid artery plaque score (see summary Table 
6).  The adjusted odds ratio for arsenic and the risk of atherosclerotic plaque was 1.2 (0.4-
3.4) for 0.1-19.9 years of arsenic-containing groundwater exposure and 2.3 (0.8-6.4) for 
≥20.0 years exposure among 463 Taiwanese adults (test for trend p-value=0.045) (Wang 
2002).   In that study, however, the individuated measurements of arsenic were not 
available and the relationship between plaque and each stratum of arsenic exposure was 
not shown. 
CIMT increase and presence of plaque are correlated and are both potentially useful in 
predicting the long-term risk of stroke.  However, CIMT and plaque represent different 
steps in the biological development and progression of carotid artery atherosclerosis. In 
general, carotid plaque score is a marker of atherosclerotic disease due to the deposition 
of cholesterol, activated macrophages, and other inflammatory cells on the endothelial 
layer.  In spite of plaque being rare in the common carotid artery, a fairly high number of 
participants in this study had atherosclerotic plaque, confirming that the participants in 
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this study were at high risk for vascular disease events that later developed throughout the 
study period (Moon 2013).  By contrast, CIMT thickening represents medial hypertrophy 
of the carotid artery due to smooth muscle proliferation from shear and tensile stress.  
Thickening of the medial layer is more representative of chronic high stress on the 
smooth muscle wall and more representative of hypertension.  As such CIMT represents 
an earlier process in the development of atherosclerotic disease than plaque score.  Given 
the observation of less than 10 years between baseline visit and carotid imaging, the 
development of early changes in the setting of arsenic exposure, but not later changes, is 
biologically plausible. 
This study differs from other reports on the relationship between arsenic and carotid 
artery disease in important methodological, environmental, and clinical ways. We have 
been able to estimate the individual’s actual arsenic exposure using creatinine-adjusted 
urinary arsenic concentration.  Most studies in low-income populations have depended 
upon ecological understanding of arsenic exposure, including random arsenic levels in 
the groundwater and years of residence.  In a recent systematic review of arsenic and 
vascular disease, nine studies specifically reported the relationship between arsenic 
exposure and stroke, all of which lacked individuated arsenic measurements (Chiou 1997, 
Yuan 2007, Meliker 2007, Yoshikawa 2008, Wade 2009, Xia 2009, Lisabeth 2010, 
Cheng 2010, Medrano 2010, Chen 2011). Of the previous four studies on carotid vascular 
disease and arsenic, only the most recent studies, of Mexican children and Bangladeshi 
adults, measured urinary arsenic concentrations in individuals (Table 15).  Neither of 
these included plaque score.  Although groundwater estimates provide detail on the 
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potential environmental exposure, they may not as accurately reflect the actual inorganic 
arsenic intake in individuals.  The potential for unmeasured confounders is high in 
ecological studies (Greenland 1989), and retrospectively recalling duration of residence is 
subject to recall bias.  The Strong Heart Study cohort by contrast followed participants 
prospectively over time, allowing for the consideration of a large number of potential 
confounders at study baseline.    
Arsenic levels in other studied locations are higher compared to the Central and 
Southwestern United States.  Elsewhere, such as in parts of southwestern Taiwan and 
Bangladesh, arsenic is found in a range considered to be toxic by the WHO and European 
Environmental Protection Agency.  Relatively little is known about arsenic ingestion at 
the low- to moderate level that occurs in the groundwater in the U.S. and to which a 
larger population is almost certainly exposed globally. It is possible that arsenic in low- 
to moderate levels has a less potent or less immediate effect on the development of 
carotid atherosclerosis and a critical threshold exists for arsenic to etiologically relate to 
both atherosclerosis and thickening of the carotid vascular wall.   
In the present population, there was a strikingly high prevalence of diabetes mellitus, 
current or previous smoking, alcohol use, obesity, and hypertension.  This population is 
at high risk for carotid atherosclerosis in the absence of arsenic exposure and it is 
possible that the effect of arsenic is stronger in populations that lack these more important 
risk factors.  In other reported studies (Ebrahim 1999), the average CIMT was as low as 
0.60 mm in women and 0.66 mm in men (vascular disease free participants, mean age 57 
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years, in the U.S. Atherosclerosis Risk in Communities) (Heiss 1991) and 0.65 mm in 
women and 0.69 mm in men in the Vascular Aging Study (mean age 65 years) 
(Bonithon-Kopp 1996). The highest CIMTs are generally reported in the oldest age 
groups, including  the Seven Countries Study (mean 1.5 mm, age range 70 to 89 years) 
(Salonen 1994) and Cardiovascular Health Study (age 65 years and above: women 1.35 
mm and men 1.57mm) (O’Leary 1999). Plaque prevalence is also high in other studies 
including a range of 24% in the MONICA Project in Germany (ages 25-65 years) 
(Gostomzyk 1988) to 93% in the Seven Countries Study in Finland (Salonen 1994).  The 
combined assessment of multiple carotid outcome measurements here helps confirm that 
the findings are indeed pertinent to range of ways in which the carotid artery can be 
usually noninvasively studied. 
This study had several strengths. The large, well-characterized cohort is ideally suited to 
study carotid atherosclerosis given its initial design to understand the vascular disease 
prevalence in American Indians at a time when such risk was poorly described.  To date, 
no other study that we are aware of has reported on the risk factors for CIMT in a large 
population of this ethnic background.  The results herein demonstrate that the traditional 
risk factors for higher CIMT and carotid atherosclerosis, including age, sex, systolic 
blood pressure, diabetes, smoking, and waist-to-hip ratio, are also important risk factors 
in American Indians.  While confirming these recognized risk factors, we identified a 
dose dependent risk between arsenic and CIMT.  Our study is also the first to report on 
the risk of carotid disease in the setting of lower than toxic levels of arsenic, a setting 
much more likely to occur than the levels reported in the available, published studies.   
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Our study also had several limitations.  It would be ideal to study the risk of carotid 
atherosclerosis in a longer period of follow up that occurred in the Strong Heart Study.  
Our follow up period ranged from 6 to 9 years overall.  Not all participants participated in 
the carotid testing and participants who did not complete carotid measurements were 
necessarily excluded.  Although there is no medical reason that separates participants 
who did and did not undergo carotid ultrasonography, we cannot fully exclude the 
possibility that people who did not have carotid artery measurements were in some way 
different in their carotid artery endpoint measurements.  For instance, participants who 
died before follow up could not get CIMT assessed. There may also be several risk 
factors related to absolute low income that include arsenic exposure and confound the 
relationship between arsenic, low socioeconomic status, and carotid artery disease. While 
the number of educational years attained is used here as a proxy for socioeconomic 
status, it is an imperfect measure for addressing all of the various health behaviors that 
accompany low income.  In such cases, arsenic exposure itself may simply be a proxy for 
health behaviors that are imperfect and do not maximize health in various ways.  At the 
same time, adjustment for location or education could result in over adjustment, as 
arsenic exposure tracks with location and socioeconomic status. Adjustment for these 
location and education can result in over adjustment.  In order to display this relationship 
as clearly as possible, we have shown models that include and exclude adjustment for 
study center. Since arsenic exposure can never be ethically studied prospectively or 
randomized, the level of evidence for arsenic exposure and health risk necessarily rests 
upon data such as available here.  
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In summary, we observed a significant, independent risk of low- to moderate exposure to 
inorganic arsenic on carotid intimal medial thickness but not on the presence of 
atherosclerotic plaque or the atherosclerotic plaque score in this large cohort of American 
Indians in the United States.  Although this study employs the carotid arteries, 
atherosclerosis is a diffuse, generalized process in the body and the imaging findings in 
the carotid arteries may also be considered as an in vivo biomarker of general vascular 
health.  Our results improve the quality of evidence for the relationship between CIMT 
and arsenic and confirm that arsenic exposure at levels deemed to be low- to-moderate 
may still be harmful to long-term vascular health. Such data were previously lacking.  
Meanwhile, several details regarding the genetic susceptibility, degree and chronicity of 
exposure, and relationship to traditional vascular risk factors remain to be more fully 
explored.   
Concluding Remarks 
In the preceding three studies, I have discussed the putative risk of three separate risk 
factors for stroke that are justifiably considered non-hereditary and more often a result of 
an individual’s setting rather than any clear genetic predisposition.  It can be argued that 
the combination of location and behavior are key to environmental risk factors.  For 
instance, the mere growth of palm trees with betel nut, local prevalence of HIV infection, 
or presence of arsenic in groundwater does not lead to necessary uptake or exposure to 
that risk factor.  In this case, as in many cases of stroke risk, individual behavior is 
crucial.  Given that human behaviors are necessary to acquire environmental risk in these 
three cases, there is a valuable role for education-based interventions.  Unlike other 
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environmental risk factors for stroke, such as air pollution, ambient temperature, or 
latitude, behavioral change does not necessarily require removing the individual from his 
or her environment in order to mitigate risk.  
Most of the risk seen in stroke can be attributed to known risk factors, those that the 
American Heart Association, major epidemiological cohort studies, and guidelines-
setting organizations have already identified as major stroke risk factors.  These risks 
most notably include systolic hypertension and age.  If all other risk factors were ignored 
and only systolic hypertension was uniformly addressed, the global burden of stroke 
would be significantly reduced.  Systolic hypertension has a magnitude of effect well 
beyond the risk conferred by any of the three risk factors above, and indeed, beyond all 
three risk factors combined.   Appropriately, the global burden of hypertension is starting 
to garner attention.  It is likely that 1 in every 4 adults has hypertension globally.  Stroke 
is largely an end-organ manifestation of hypertension. Addressing the large minority of 
adults who have hypertension in a meaningful and sustained way would be a major global 
public health success.    
What are the barriers to stroke research in low-income settings?  
In spite of a large number of published papers reporting stroke is a concern in developing 
countries, there are limited data from the lower-income settings.  When considering the 
number of reports compared to the number of likely stroke deaths and disability-adjusted 
life years, the number of data-driven reports on stroke in vulnerable population remains 
surprisingly small.  Data quality is also limited in many published reports and several 
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countries still lack reportable information and data to inform policy. The accuracy of the 
Global Burden of Disease (Kim & Johnston 2011, Murray et al. 2012, Feigin et al 2014), 
its broad inferences and lack of inputted data, make all estimates questionable, 
particularly in low-income settings. Most literature totters on just a handful of available 
studies that are repeatedly cited versus implementing new efforts to study stroke in new 
settings in a standardized fashion. 
Based on my experience, I would suggest the following ten reasons why stroke remains 
unstudied and under-studied in a variety of resource-limited regions globally. 
1) Lack of recognition of stroke as a “public health” problem 
2) Lack of clarity and awareness that stroke is a “human development” problem 
3) Conflation of stroke as a lifestyle issue rather than a scientific challenge 
4) No major organization advocating for neurological disorders globally 
5) Limited numbers of trained health professionals in the neurosciences to advocate 
for stroke care 
6) Reduced patient self-advocacy due to stigma and disability with the brain 
disorders, e.g. stroke causes aphasia making patient advocacy for that sequela 
particularly difficult 
7) Absence of reliable biomarkers and inadequate case definitions for stroke 
8) Limited access to neuroimaging globally, limiting sub classification and 
separation from competing diagnoses such as meningitis, cerebral malaria, and 
tuberculosis involving the central nervous system 
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9) Limited baseline data on stroke in populations and paucity of stroke registries 
10)  Lack of stroke treatment options including an absence of affordable technologies 
and confirmed efficacious interventions 
 
Stroke in low- and middle-income countries 
Population-based approaches to stroke include stroke prevention, emergent management, 
rehabilitation, and secondary prevention, all of which are severely lacking in most low-
and middle-income countries (LMIC).  Stroke incidence should largely be considered to 
result from increases in the prevalence of recognized cerebrovascular disease risk factors 
in LMIC.  However, genetic predisposition and health behaviors that predispose to stroke 
may be exacerbated by weak health systems, unregulated industries, and limited public 
health messaging for chronic disease risk factors.  The widespread uptake of cigarette 
smoking and alcohol; limited diagnosis and access to treatment for diabetes and 
hypertension; physical inactivity due to increasing urbanization and motorized 
transportation; dyslipidemia and poor intake of fruit and vegetables due to “Westernized” 
diets; and poor awareness of family history of vascular disease due to premature deaths of 
older relatives from infectious diseases may all increase the risk of stroke in LMIC.  
The growing burden of young-onset-stroke in low- and middle-income countries 
Stroke is not a disease exclusively of the elderly.  Stroke in young adults – defined 
roughly as onset between ages 18 to 50 years old - accounts for approximately 5% of all 
strokes in Western countries, but, where studied, between 19% and 30% of strokes in 
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LMIC (Marini et al 2011).  There is almost certainly an increasing burden of young-onset 
stroke in LMIC in contrast to the “graying” of other epidemics such as HIV/AIDS. 
Large, clinical studies of stroke epidemiology in young adults have been performed 
almost exclusively in high-income settings, most notably including Scandinavia, East 
Asia, and the United States.  In high-income settings, more than 20% of people ages 15 to 
44 years old die within one month of their first stroke (Groppo et al 2012). In LMIC, the 
few studies reported are retrospective and lack uniformity in clinical evaluation of young 
stroke patients (Nayak et al 1997, Zhang et al 2012).  However, young-onset stroke is an 
emerging public health issue for countries of all income levels.  Among the young, there 
are longer periods at risk for repeat vascular events, more years of healthy life sacrificed, 
and an unexpected loss of productive working years with limited employment and 
rehabilitation prospects.  For survivors, young-adult-onset stroke may lead to levels of 
disability that are financially untenable for families and health care systems in LMIC.  
Youth and young adults are increasingly called to provide care to their parents with 
vascular disease, and prematurely so compared to the more late-onset stroke that occurs 
in predominantly older populations in high-income settings with relatively established 
support networks.   In this way, addressing stroke also prevents financial demise and 
missed opportunities for the next generation who could be alleviated of the burden of 
long-term parental care.   
The Neglected Stroke Epidemic in Sub-Saharan Africa 
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There is particularly a neglected and growing epidemic of stroke in Sub-Saharan Africa 
(SSA).  In spite of the high number of people living in the region, very limited data on the 
burden of stroke in this region exist (Sokrab et al 2002, Damasceno et al 2010, Akubaka 
et al 2010, de Villiers et al 2011, Damorou et al 2011, Mudzi et al 2012, Kengne et al 
2012, Heikinheimo et al 2012). The published reports suggest a high stroke prevalence 
with disproportionate mortality and morbidity compared to higher-income settings. SSA 
is now among the only places in the world where vascular disease is not the established 
leading cause of death (Lozanos et al 2012).  As the HIV-infected community survives 
longer, the burden of vascular diseases will also grow.  Recent studies of blood pressure 
distribution in SSA reveal a high burden of hypertension and its sequelae, including 
among HIV-infected groups (Bloomfield 2011 et al, Kaddumukasa et al 2012, 
Damasceno et al 2012, Mateen et al 2013). Meanwhile, HIV-infected individuals in SSA 
often receive care through vertical programs that are specific to HIV. These clinics may 
lack resources or skilled personnel to address other important disease risk factors such as 
hypertension or diabetes. While countries in SSA undergo the last stages of the 
epidemiological transition, the relationship between chronic HIV infection, antiretroviral 
use, and stroke will become increasingly important.     
A prospective study of betel nut and betel nut cessation? 
The first paper reports the potential role of betel chewing in the development of stroke.  
However, many questions remain unanswered.  Betel nut may be chewed by 
disproportionately older people in society or those with more detrimental lifestyle habits 
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such as immobility, high-fat diets, and cigarette smoking.  The prospective study of betel 
nut chewing versus not with matched subjects on age and sex would be of interest.  The 
use of a specific amount and type of betel that can be quantified and recorded would 
improve this area of work. Given the widespread use of betel nut, there are many 
potential participants in the betel chewing group but perhaps fewer willing participants in 
the non-betel chewing group!  The roll-out of betel cessation campaigns, particularly in 
pregnant women, and the regulation of pre-packaged quid advertising would be of 
interest in future studies.  
Studies of betel nut may be difficult to tease apart from the way of life that betel 
represents.  In several locations in the Western Pacific and Indian Subcontinent, betel is 
chewed with a regularity and heterogeneity that makes it difficult to study.  Future studies 
of betel nut and stroke would best employ a prospective design that provides the 
substance in a standardized fashion; prospectively ascertains, measures, and records 
comorbidites and risk factors; and follow in vivo biomarkers such as C-reactive protein, 
cholesterol, and betel nut metabolites over time.  There is also a strong impetus to 
improve pre-human studies of alternative tobaccos such as betel nut including animal 
studies that would help lead to the study of vasoreactivity, and soluble inflammatory 
marker release as well as teratogenicity.  Basic biochemical analyses of what constitutes 
betel nut and its active metabolites would also be of value given the wide distribution of 
its use. 
Stroke:  Another nail in the coffin for arsenic ingestion  
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The study on arsenic as an emerging risk factor for stroke and subclinical atherosclerotic 
disease is yet another negative impact of arsenic.  The World Health Organization’s 
listing of arsenic as a chemical of major public health concern is based on its 
carcinogenicity more than its long-term potential to influence vascular health.  This is 
also true of betel which is much better known to cause oral cancers than it is to change 
vascular disease risk. The recommendations by the Environmental Protection Agency, 
including a cutoff point for arsenic in water, may over time require re-review.  The safest 
comment is likely that there is no definite safe ingestion of arsenic in groundwater and 
food and the long-term consequences of arsenic on health may include vascular disease at 
levels previously considered acceptable and non-carcinogenic.  
Future directions for stroke research and care: what is truly innovative?  
Although stroke incidence is increasing substantially in LMIC (Feigin et al 2009) and has 
a broad range of etiologies, the impact of disease can be mitigated.  Improved care may 
be achieved in several ways specific to stroke as well as expand upon other services that 
are already established for acute care, such as expansion of acute care currently in place 
for cardiovascular disease.  Technology can enhance the efforts for stroke in LMIC, 
particularly in rural and resource-limited locations.   
Services for stroke in LMIC and vulnerable populations would benefit from a 
combination of programmatic approaches and should not simply model the inpatient-
predominant and older adult focus of stroke treatment in high-income settings.  Diagonal 
approaches that capitalize on existing services and treatments could incorporate stroke 
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into usual care. Stroke in the peri-partum period, environmentally contaminated regions, 
neonatal pre-term hemorrhage, and the adolescent with coagulopathy such as sickle cell 
anemia, must all be included within the broad rubric of stroke care in LMIC.  
Introduction of comprehensive stroke units and their scale up in the lowest-resourced 
settings is required - alongside the more generally recognized need for interventions for 
HIV/AIDS, tuberculosis, and malaria. Widespread screening for hypertension and 
education on antihypertensive treatments is currently the most necessary, available, and 
affordable opportunity to broadly reduce lifetime risk of stroke.   
 
New drug development for acute stroke intervention is severely needed.  Emergent 
treatments for stroke, such as intravenous thrombolysis, are expensive, require expert 
providers, and difficult to access even in wealthier settings.  Perhaps most neglected to 
date, the incorporation of stroke rehabilitation and secondary prevention of vascular 
diseases into health systems is necessary.  Stroke rehabilitation is evidence-based and 
effective in reducing long-term disability and reestablishing survivors’ core activities of 
daily living.  Several randomized trials attest to the value of stroke rehabilitation, 
including such measures as intensive physiotherapy, speech therapy, dietary 
modifications, occupational therapy, and environmental alterations.  Stroke rehabilitation 
improves mobility, promotes independence, and maintains human dignity.   
From epidemiology to action:  two interventions for stroke in resource-limited settings 
1) An African Surveillance Network and Clinical Trials Network for Stroke? 
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The next steps in the study of stroke in SSA almost certainly require coordination and 
planning of multiple, predominantly urban centers.  Through my thesis and non-thesis 
work, I have established several collaborators throughout southeast Africa and hope to 
work with the American Heart Association and World Stroke Organization to create a 
“Get with the Guidelines Africa” program.  This can be modeled after the popularized 
Get with the Guidelines in the U.S. and relate to resource-limited areas more specifically.  
It is my hope to include collaborators who range from psychiatrists, nurses, 
physiotherapists, and cardiologists to participate in Rwanda, Tanzania, Malawi, Zambia, 
Botswana, Zimbabwe, and Uganda.  This, in my opinion, would be a major step forwards 
in understand stroke care.  With the rising use of cell phones internationally, the 
opportunity to “crowd source” information on stroke would be a welcome 
accomplishment in building upon nearly non-existent data in this region.   Get with the 
Guidelines in the U.S.A. currently reaches 2.7 million people and Get with the Guidelines 
Africa has the potential to reach millions more.  
2) Does fluoxetine have a role in post-stroke recovery in resource-limited settings?  
Currently, there are no pharmacological treatment options for motor recovery after 
stroke. One recent phase III clinical trial of fluoxetine, a selective serotonin reuptake 
inhibitor (SSRI), showed improved motor recovery among 118 ischemic stroke survivors 
in France (FLAME Study) (Chollet et al. 2011).  Fluoxetine, and potentially other SSRIs, 
may be neuroprotective by reducing inflammation within the central nervous system and 
promoting neuroplasticity. A Cochrane review (Mead et al 2012) reported 52 clinical 
trials, including 4059 patients: those on fluoxetine post-stroke were less likely to be 
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depressed, anxious, neurologically impaired, dependent, or disabled. However, an excess 
of adverse events was noted in the treated group, making the beneficial use of fluoxetine 
in all recovering stroke patients unproven. Larger studies are needed, particularly in 
resource-limited settings and among HIV-infected stroke populations.   
 
Part of my work following completion of the dissertation is to test the use of fluoxetine in 
Harare Central Hospital’s stroke unit, a location funded by the Medical Education 
Partnership Initiative (MEPI).  This study will join a larger, established network of 
clinical trials alongside investigators in Australia (Dr. Graeme Hankey), the United 
Kingdom (Professors Gillian Mead, Martin Dennis), and Sweden (Dr. Veronica 
Murray). These centers also see the need for large randomized controlled trials of 
fluoxetine for stroke recovery, and have initiated the Assessment oF FluoxetINe In 
sTroke recoverY (AFFINITY) trial in Australia ( Australian New Zealand Clinical 
Trials Registry: ACTRN12611000774921), the Fluoxetine Or Control Under Supervision 
(FOCUS) trial in the United Kingdom (ISRCTN83290762).  This network is also 
planning the EFFECTS trial in Sweden.  In that proposal, currently under review, and 
with additional confirmed funding support, I propose to study fluoxetine as a treatment 
for post-stroke depression and accelerated motor recovery with collaborators in 
Zimbabwe. The proposed hypothesis is: Daily administration of fluoxetine 40 mg by 
mouth daily within 7 days of onset of acute ischemic stroke will lead to a clinically 
relevant improvement on the Fugl-Meyer motor score (FMSS) (≥12 points) at 90 days 





There is almost certainly synergy between traditional and emerging risk factors in stroke.  
These risks together raise complex policy questions around such issues as the legality of 
alternative forms of tobacco, environmental justice for marginalized populations, and re-
financing programs for health to move beyond infectious and communicable diseases to 
the more common non-communicable disorders that adults in LMIC more often acquire.  
Organization, coordination, and training remain major barriers to improving the incidence 
and mortality of stroke in many countries.  As these papers have shown, even in an 
established health care system, stroke continues to heavily burden populations.  Stroke 
prevention and care now require a much needed cadre of experts and organized initiatives 
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Table 1. Population-Based Mortality from Stroke by Year for persons 20 years and older 















      
Year Male Female Total   Male Female Total 
Male Female Total 
2005 107057 117693 224750  691 520 1211 
193 171 364 
2006 106512 118026 224538  653 482 1135 
172 171 343 
2007 105626 118413 224039  678 589 1265 
143 195 338 
2008 103579 118639 222218  669 590 1259 
110 95 205 
Total 422774 472771 895545   2691 2179 4870 
616 632 1250 
100 
 








Female (%) 50.9% (636/1250) 47.4% (130/274) 0.336 
Age (years) (mean, 
range) 
20-29 years (%) 
30-59 years (%) 
60-69 years (%) 
70-79 years (%) 
80-89 years (%) 
















Level of Education 
None (%) 
Primary School (%) 
Secondary School (%) 












Death at Home (%) 91.0% (1138/1250) 42.2% (113/268) <0.001 
Most common 
occupations (%) 
1. disabled physically 
or mentally 
44.3% (554/1250) 
2. housewife / 
housework 
22.5% (281/1250) 







1. housewife / 
housework 
29.6% (81/274) 
2. disabled physically 
or mentally 
20.4% (56/274) 
3. farmer / landowner 
10.2% (28/274) 
4. farm worker / daily 
laborer (landless) 
5.1% (14/274) 
5. no occupation 
5.1% (14/274) 
--- 
Hypertension (%) 47.4% (549/1158) 5.8% (16/274) <0.001 
Diabetes Mellitus (%) 18.0% (211/1173) 3.3% (9/270) <0.001 
Coronary Artery Disease 
(%) 





38.1% (475/1246) 29.3% (39/133) 0.046 
Pipe smoking/hookah 
(%) 
9.3% (115/1243) 6.8% (9/133) 0.342 
Betel consumption (%) 83.9% (1049/1250) 65.4% (87/133) <0.001 
Tobacco powder/gool 
(%) 
















Table 3. Distribution of Potential Risk Factors of People who died of Stroke by Sex 
 Women (n=632) Men (n=618)  
Age (years) (mean, 
range) 
72.6 (20.6-101.1) 71.9 (21.7-96.9) 
0.316 
Hypertension 47.7% (281/589) 47.1% (268/569) 0.836 
Diabetes 15.2% (90/592) 20.8% (121/581) 0.013 
Coronary Heart Disease 5.7% (34/601) 6.6% (39/587) 0.479 
Level of Education 
None (%) 
Primary School (%) 
Secondary School (%) 













Cigarette smoking/biri 5.9% (37/631) 71.2% (438/615) <0.001 
Pipe smoking/hookah 1.3% (8/631) 17.5% (107/612) <0.001 
Betel consumption 90.8% (574/632) 77.5% (479/618) <0.001 

















Table 4. Risk Factors for Stroke compared to Unintentional Injury Deaths  
Potential Risk Factor Odds Ratio* 95% Confidence 
Interval 
p-value 
Hypertension 7.94 4.44-15.54 <0.001 
Diabetes 2.54 1.21-6.21 0.02 
Betel nut 2.36 1.45-3.80 <0.001 
Heart disease 1.37 0.45-5.95 0.62 
Cigarette smoking 1.41 0.82-2.45 0.22 
Tobacco powder 1.15 0.30-7.64 0.86 
Cigar/hookah pipe 
smoking 
0.94 0.45-2.18 0.88 













Table 5. Sensitivity analysis for regression coefficients and relative risks for significant 
risk factors in cox proportional hazards regressions for stroke profiles in male 




 Total MACS Cohort (n=3945) 





Risk Factor     
Age 
(per 10 year 
increase) 
0.049 1.63  
(1.33-
1.99)** 




0.015 1.16  
(1.10-
1.24)** 








Diabetes mellitus 0.34 1.41  
(0.97-
2.04) 
2.05 (0.42-10.0) 0.37 
Cigarette 
smoking 
0.52 1.69  
(1.27-
2.23) 
1.35 (0.72-2.55) 0.36 
Cardiovascular 
Disease* 
0.55 1.73  
(1.68-
1.78) 
2.47 (0.70-8.69) 0.16 




Left  ventricular 
hypertrophy 











Table 6. Point System of the Framingham Study for probability of stroke within 10 years 
for men aged 55-84 years and free of previous stroke (Wolf 1991) 
 
 Points 
 0 1 2 3 4 5 6 7 8 9 10 
Risk Factor            














































No  Yes         
Diabetes No  Yes         
Cigarettes No   Yes        
Cardiovascular 
Disease 
No   Yes        
Atrial 
Fibrillation 




No      Yes     
 
Note:  To assess the sensitivity of our findings to errors in the reporting of stroke events, 
we reran our analyses using only confirmed events by medical records review in the 
MACS (45 strokes among 40 subjects), as described in the methods section. When 
excluding all unconfirmed events, we found the estimated baseline FRS-S for HIV+ 
patients who experienced a stroke to average 4.8% (range 0-11%) compared to HIV- 
participants with stroke whose baseline FRS-S averaged 6.5% (range 0.3%-26%) 
(p=0.11).  In addition, for the second analysis we refit a Cox proportional hazards model 







Table 7. Comparison of Baseline Demographic and Clinical Features related to Stroke 
Risk in the Framingham Heart Study (FHS) and Multicenter AIDS Cohort Study 
(MACS) 





























   
Variables in FRS-S       
Mean Age, Range (y)* 65.4, 55-84 41.0, 17-
69 

















16.1 8.9 21.4 5.2 13.2 0.41 
Diabetes mellitus (%) 10.6 1.5 1.8 1.5 2.6 0.98 
Cigarette smoking (%) 33.8 39.5 42.9 33.2 36.8 <0.001 
Cardiovascular disease** 
(%) 
22.2 2.7 8.9 1.5 7.9 1 












Other Variables, not in 
FRS-S 
      
 HIV-Related Variables       
HIV (%) Unknown 100 100 0 0 <0.001 
HIV Viral Load at 




7,194 (340) N/A N/A N/A 
CD4 Count at Baseline 
(cells/mL) 
Mean (IQR) 
N/A 688  
(401) 





No. of Years since HIV 
diagnosis, Mean (IQR) 
N/A 5.9 (11.6) 6.4 (11.6) N/A N/A N/A 
Duration on HAART 
(years), Mean (IQR) 
N/A 0.9 (0.3) 1.0 (0.2) N/A N/A N/A 







65-29-7 75-20-5 79-18-4 82-16-
3 
<0.001 
Body Mass Index (kg/m2)  
Mean (IQR) 
Unknown 24.2 (4.0) 24.4 (5.1) 24.6 (4.4) 25.2 
(3.5) 
0.05 
Alcohol, Average in no. 
drinks per week, Mean 
(IQR) 
N/A 7.0 (10.0) 7.1 (10.1) 7.4 (9.6) 6.6 
(8.4) 
<0.001 
Use of Cocaine or Crack 
in the past 2 years or the 
previous study visit (%) 
N/A  35 20 29 29 <0.001 
Any Other Drug Abuse 
by History, including 
Poppers, Marijuana, 
Hash, “Uppers” or other 
drugsǂ 
N/A 68 71 69 74 0.37 
 
Legend: *At the time of study entry in the HAART era,   **As stated in methods section in the 
MACS †More than 50% of participants had missing values.  ǂIncludes crystal meth, meth, speed, 















Table 8. Regression coefficients and relative risks for significant risk factors in cox 
proportional hazards regressions for stroke profiles in male Framingham participants ages 








Total MACS Cohort 
(n=3945) 










Risk Factor       
Age 
(per 10 years) 
























(per 10 mmHg 
increase) 

































0.55 1.73  
(1.68-1.78) 





Atrial fibrillation 0.60 1.82  
(1.01-3.29) 
- - - - 
Left  ventricular 
hypertrophy 
0.79 2.20  
(1.26-3.84) 
- - - - 
HIV - - - - 2.16 (1.39-
3.31) 
<0.001 
*In MACS, limited to self-reported myocardial infarction ascertainment. 
**Given for 10-unit changes, as per the original Framingham study; all other variables reported 
dichotomously.  In FHS, all variables were significant at a p<0.05 level.  





Table 9. Selected Clinical Studies of Stroke in HIV-Infected Adult Patients Performed in 







Study Design Study 
Location 











22 Incidence rate similar 
between HIV+ and HIV- 
young Africans but higher 
incidence of large vessel 
cryptogenic strokes in HIV+ 






15 Ischemic stroke more 
common in HIV+ 
individuals 





35 Similar patient 
characteristics between 
HIV+ and HIV- patients 
Cole (2004) Retrospective 
medical records 






12 AIDS is strongly associated 
with both ischemic and 
hemorrhagic stroke 





56 No difference in 
angiographic, cardiac, or 
serologic tests between 
HIV+ and  HIV- groups 
Ortiz (2007) Hospital-based 
retrospective 
chart review 


















67 HIV vasculopathy occurred 
in 20% of patients 
Corral (2009) Retrospective 
hospital-based 
cohort study 
Madrid, Spain 25 Stroke incidence is 
increased in HIV treated 
with HAART 
Lifson (2010) Events recorded 





38 55% of strokes were 
confirmed based on defined 








Denmark 140 Increased risk of ischemic 
stroke in HIV, with and 









10,944 Increased number of 
admitted stroke patients with 
HIV in recent years 
Chow (2012) Cohort study Boston, U.S.A. 132 Ischemic stroke rates 
increased in HIV, especially 











53 Ischemic stroke incidence 
~1.5 times higher than a 
population-based cohort; 



























Carotid Measurement Measure Value 




Number of Effected CCA Segments 









































8   (0.3) 






0.75 (0.60, 0.87) 





0.74 (0.60, 0.85) 
Far Wall Thickness of CAA, mean 




0.75 (0.63, 0.84) 
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Table 11. Characteristics of the 2478 Study Participants at Study Visit including Carotid 
Ultrasound Measurements 
Characteristic Measure Value No Carotid 
Plaque 
Carotid Plaque 
Mean age (standard 
deviation ((SD)) 
years 55.3 (7.6) 52.6 (6.5) 56.8 (7.8) 
Female sex n (%) 1563 (63) 613 (70.2) 950 (59.2) 
Inorganic plus methylated 










Systolic blood pressure 
(SD) 
mmHg 125.5 (18.4) 123 (16.1) 127.1 (19.4) 
Diastolic blood pressure 
(SD) 




diagnosis n (%) 
853 (34.5) 257 (29.5) 596 (37.2) 
Hypertension medication 
treatment 
yes (%) 522 (21.1) 162 (18.6) 360 (22.4) 
Fasting blood glucose 
(SD) 
ng/mL(check) 145 (72.4) 137 (67.2) 150 (74.7) 
Hemoglobin A1c (SD) % 6.6 (2.32) 6.3 (2.24) 6.7 (2.35) 




both, none n 
(%) 
433 (17), 215 
(9), 9 (0), 1821 
(73) 
117 (13), 54 
(6), 1 (0), 
701 (80) 
316 (20), 161 
(10), 8 (1), 
1120 (70) 
Serum triglycerides (SD) mg/dL 147 (123) 137 (121) 152 (124) 
Serum total cholesterol 
(SD) 
mg/dL (check) 191 (37.5) 183 (36.2) 196 (37.4) 
Serum high density 
lipoprotein (SD) 
mg/dL 46.0 (13.0) 46.4 (12.7) 45.8 (13.3) 




Serum fibrinogen (SD) mmol/L 
(check) 
299 (75.7) 300 (74.5) 298 (76.4) 
Estimated glomerular 
filtration rate    >60 
mL/min/1.73m2 
n (%) 2258 (92.7) 826 (95.9) 1432 (90.9) 
Waist-to-hip ratio (SD) Cm 0.948 (0.07) 0.941 (0.07) 0.951 (0.07) 
Body mass index (SD) kg/m2 31.0 (6.1) 32.5 (6.7) 30.2 (5.6) 
Height (SD) Cm 165.1 (9.0) 164.2 (8.8) 165.6 (9.1) 
Weight (SD) Kg 84.6 (17.8) 87.7 (19.4) 83.0 (16.7) 
Cigarette smoking  current, 
previous,  
never n (%) 
790 (32), 861 
(35), 




569 (36), 544 
(34), 489 (31) 
Smoking pack-years (SD) years 15.4 (19.4) 12.0 (16.9) 17.0 (20.3) 
113 
 
Alcohol use current, 
previous,  
never n (%) 
1026 (41), 





668 (42), 674 
(42), 259 (16) 
Educational attainment 
level (SD) 
years 11.3 (3.0) 11.6 (2.9) 11.2 (3.0) 
Study location Oklahoma, 
Arizona, North 
and South 
Dakota n (%) 
857 (35), 809 




541 (33), 457 
(28), 607 (38) 
 



















Table 12.  Relationship between traditional cardiovascular risk factors, urinary arsenic 
















































































































































-0.952      
(-1.39,       
-0.516) 



































































































































































































































<0.01 120 (27.4, 
21.2) 










































































ⱡ sum of inorganic and methylated arsenic species, natural logarithm (μg/L creatinine) (ln As/ln2) 
*For these variables, the model also includes the variable of interest in each model.   
Model A includes age, sex, education, ethanol intake, smoking. 
Model B includes age, sex, education, ethanol intake, smoking, waist-to-hip ratio, diabetes 
mellitus, systolic blood pressure, serum triglycerides, and HDL.  


































































































































































































































































































































































































































































































Model 1 includes age, sex, education, ethanol intake, smoking. 
Model 2 includes age, sex, education, ethanol intake, smoking, waist-to-hip ratio, diabetes 
mellitus, systolic blood pressure, serum triglycerides, and HDL.  
Model 3 is Model 2 + Study Center. 









Table 14: Relationship between traditional risk factors, arsenic, and carotid 
atherosclerotic plaque score (score 0 through 4+; n=870, 35%; n=528, 21%; n=502, 20%; 







for Age and 



















<0.001 1.08 (1.07, 
1.09) 
<0.001 






<0.001 1.44 (1.22, 
1.69) 
<0.001 































0.001 1.00 (1.00, 
1.00) 
<0.001 






<0.001 2.33 (1.98, 
2.75) 
<0.001 















































































































































































Model B includes age, sex, education, ethanol intake, smoking, waist-to-hip ratio, diabetes mellitus, 
systolic blood pressure, serum triglycerides, and HDL.  
























Age √ √ 
Male √ √ 
Systolic blood pressure √ √ 
HDL  √  (lower) √ (higher) 
Total Cholesterol  √ 
Smoking Cigarettes √ (former vs. never) √ (current vs. never) 
Waist-to-Hip Ratio √  
BMI  √ 
Diabetes  √ 
Fasting Blood Glucose  √ 
Arsenic √  














































Figure 3. Histograms of the Framingham Risk Score for Stroke point composition of the 




Figure 4. Histograms of the Framingham Risk Score for Stroke point composition of the 
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